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INTRODUCTION.

The importance of acute lobar pneumonia and the need for means
to prevent its ravages are now generally recognized. Among the
infectious diseases pneumonia ranks next to tuberculosis as a cause
of death, and in many of our large cities it kills more persons each
year than does tuberculosis itself. In the public mind pneumonia
is generally thought to affect mainly the very young and the old and
decrepit. As a matter of fact, over half the cases occur between the
ages of 20 and 50, during the period of greatest activity.
Although it occurs chiefly in endemic form, small and even large
epidemics are not unk.11:own. It was the most serious disease which
threatened the success of construction of th'e Panama Canal, and its
prevalence in certain regions where large numbers of susceptible
workers·are brought together, as in the mines of South Africa, renders
it of great economic importance. Its importance as a cause of sick
ness and death among soldiers is not generally recognized, at least
in this country, in spite of the fact that in our CivH War, aside from
- dysentery and typhoid, it caused far more deaths th� any other
disease. With improvements in knowledge of preventing and treat
ing the two former diseases, pneumonia bids fair in the present war
to lead all diseases as a cause of death. Judging from the experience
in European armies, both in times of war and in times of peace 1
pneumonia is especially likely to attack raw recruits. The experi
ence among the small number of troops o� the Mexican Border,
where pneumonia occurred in epidemic form, should be a warning
of what is likely to happen in our national army when large num
bers of susceptible men are brought together during the winter
months.
Up to a few years ago the problem of preventing the spread of
pneumonia or reducing its destructive effects seemed almost hopeless.
The fact that bacteria apparently identical with those causing pneu
monia are found in the mouths of many normal persons seemed
to render any proposed measures for the prevention of infection well-
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nigh useless. Attempts to cure the disease by the serum of immune
animals had also given very incon,clusive or negative results.
During recent years there has been in progress in the Hospital of
The Rockefeller Institute a study of acute lobar pneumonia with the
special object of improving methods of treatment. Realizing that
such improvements are most likely to follow increase in knowledge
of the pathogenesis of the disease and especially knowledge concern
ing the etiologic agent itself, much time has been given to the study
of the pneumococcus, to the study of its distribution, which is
so necessary for a knowledge of the epidemiology of the disease,
and especially to a study of its immunity reactions, in order that
methods for specific treatment might be obtained. As a result
of this study, certain observations have been made and methods
have been devised whiqr have a direct practical bearing upon diag
nosis ahd treatment. These observations have been published from
time to time in papers appearing in The Journal of Experimental
Medicine and elsewhere. At the present time of emergency and
stress, however, it seems desirable that whatever is of _practical
value in this work should be made easily accessible, and, with the hope
of meeting this need, this monograph has been prepared.
In the studies which have been carried on at the Hospital of The
Rockefeller Institute, attention has been confined to pneumoni3: of
the lobar type, due to Diplococcus pneumoni�, though certain of the
results obtained are undoubtedly applicable to lobular infections of
the lung and to other pneumococcus infections as well. It is our
'purpose here, however, to consider only the application of bacterio
logic and immunologic facts to the fo�er disease.
It is not intended . to present a complete description of this dis
ease, the clinical features of which are well known. A brief general
review of the bacteriology of pneurnococcus, however, is included;
but no attempt· has· been made to present a complete review of the
entire subject. Much work which is undoubtedly important has not
been discussed, and the writers have aimed chiefly to present the re
sults of their own work and that of their associates in The Rocke
feller Institute, and to describe the technique that has been there
developed in the etiologic diagnosis an4 specific. treatment of this
disease. It is hoped that this monograph may be of aid to the
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worker in the clinical laboratory who assists in diagnosis, to the
public health worker who is attempting preventive measures, to the
manufacturer who prepares immune serum, and to the clinician who
carries out specific treatment. To meet all these requirements in a
small space has demanded that the material be very much condensed
and that, as far as possible, theoretic discussions be omitted. On
the other hand, the effort has been made to describe method� accu
rately and with considerable attention to detail, in order that they
may be employed even by those without very extensive bacteriologic
training. It has been thought best to err on the side of too minute
description of details and, in many cases, technical descriptions of.
very simple procedures, that are undoubtedly quite familiar to trained
laboratory workers, are included.
The problems concerning pneumonia which remain to be solved are
numerous, and the difficulties of successfully applying serum treat
ment to _all forms of pneumonia still seem almost unsurmountable.
Nevertheless, we now possess considerable knowledge concerning
the mod� of spread of the disease, more knowledge indeed than we
have of some other diseases that are thought preventable, and we
have perfected methods for successfully treating at least a part of the
cases. We believe that there exists at present not only the.justi
fication for, but also the duty of attempting to apply these facts on a
-larger scale, especially at this time when special danger threatens a
large part of our most valuable population, and when it is so impor
tant that human life be conserved. The application of these facts,
however, cannot be effectively made in a crude haphazard manner.
Sufficient supplies of serum of standard potency must be available
and public health laboratories, hospital laboratories, and army field
hospital laboratories must be equipped to carry out the necessary
procedures. In addition, there is needed a very close cooperation
·between the laboratory workers and those actually engaged in the
care of patients, and the latter, as well as the laboratory workers,
should have knowledge of the principles concerned and of the laboratory methods employed.

DEFINITION AND ETIOLOGY.

Acute lobar pneumonia is an acute infectious disease, the character
istic pathologic feature of which is a uniformly diffuse,, exudative
inflammation of entire portions of one or more lobes of the lung.
It has long been a question of dispute, however, whether the defini
tion of the disease shall be based on pathologic, etiologic, or clinical
features. In our opinion, as far as prevention and cure of the dis
ease are concerned, it is of the greatest importance that the chief
stress should be laid on the etiologic agent. Lobar inflammation
of the lung may undoubtedly be caused by a number of different bacteria. The vast majority of the lesions, however, are caused
by varieties of Diplococcus pneumoni(JJ. Among 529 cases diag
nosed from the clinical and pathologic features as acute lobar pneu
monia, the following were the etiologic agents concerned:
'
Diplococcus pneitmonire . ................ , . . ...... . .... . . . . .... 454
Friedllnder's bacillus...... ....... ......... .. ... . . . . ... . .. . .. . 3
Bacillus infiuenzre. .. .. . . .. .. . . ... ...... . . .. ... .. .. . . . . . . .. . .. 6
Streptococcus pyagenes .. _ .. _ ..... �. . ...... . . . . . . . .. ....... . . . .. 7
Streptococcus mucosus. . ... . . . . . ....... . . ..... .. . . . .. . ... ..... . 1
Staphylococcus aureus. ..... ... . . ....... .. .. .. . ... ... . . . . . ..... 3
fases of mixed inf�tion with combinations of Staphylococcus aureus,
Friedliinder's bacillus, B. infiuenzre, Streptococcm pyogenes, and
Streptocaccus viridans. .. .. .... . . ... . . . .. . . .... . ... ... . ... .. 6
Undetermined (most of them occurring before accurate methods for
determining the etiologic agent had been devised) . .. .. .... . .. 49

Total...................................................... 529

It is not important to discuss here whether the pulmonary lesions
due to Diplococcus pneumoni(JJ are. identical with those produced by
other microorganisms. In typical cases, possibly in all, differences
are present. At the present time, however, the differences in
lesions ·cannot be detected with certainty during the life of the pa
tient. The cases due to different varieties ·of bacteria are clinically
indistinguishable, though the typical cases due to certain organisms
7
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may present certain fairly characteristic features. With further
study of large_ series of cases in which the etiologic agent in the in
dividual case is carefully determined, it may be possible to devise
methods for making a differentia1 diagnosis on clinical groµnds. At
present we must rely on the isolation and identification of the or
gan:ism concerned in each individual case. While we recognize,
therefore, that lobar pneumonia may be due to a number of different
organisms, in our present study we prefer to 1imit the discussion to
that form due to Diplococcus pneumonire. As will be shown later,
all pneumococci are not identical, but may be differentiated into sev
eral different types. This fact is of fundamental importance- in all
that concerns prevention and treatment of this disease, and, there
fore, we believe that from the clinical standpoint, as well as from
the bacteriologic, the cases due to the different types of pneumococci,
as well as those due to other varieties of bacteria, should be consid
ered distinct clinical entities. Instead of considering lobar pneu
monia one disease, we should consider it a group of diseases. At
present we can distinguish no constant clinical or pathologic differ
ences among the cases due to the different types of pneumococci,
though certain observations suggest that a clinical differentiation,
even of these cases, may not be entirely impossible. Such a separa
tion of the cases of pneumonia is entirely analogous to what we have
become accustomed to in the typhoid-paratyphoid group of infec
tions. Clinically all the cases due to this entire group of organisms
are very similar. Their differentiation, however, has become neces
sary for epidemiologic and therapeutic reasons. It is true that the
different types of organisms in the enteric group possess slight cul
tural differences in addition to immunologic ones, while the different
types of pneumococci differ from each other, as far as we can de. tect at present, almost entirely in their immunity reactions. These
latter differences, however, from the standpoint of prophylaxis and
treatment, are much more important than cultural distinctiqns.

DIPLOCOCCUS PNEUMONUE .
.In 1881 Pasteur (21) described an organism, recovered from the saliva of a
case of rabies, which produced a fatal septicemia in rabbits and which he desig
nated microbe septicemique du salive. Almost synchronously, but quite inde
pendently, Sternberg (27) in this country reported the occurrence of a similar
coccus in the saliva of healthy individuals. The microorganism described by
these two investigators is now recognized as pneumococcus, or Diplococcus
pneumonire. At the time these observations were made, however, the pneu
mococcus was not known to be associated with disease in man. It was not,
until the systematic investigations of Fraenkel (4) several years later (1884-85)
on the e..tiology of pneumonia, and the report of Weichsel.baum (34) on the
occurrence of the pneumococcus in the blood, organs, and exudates of a large
series of cases of this disease, that the causal relationship of this organism to
lobar pneumonia was established.

The original discovery of pneurnococcus in the saliva of healthy
individuals, and the later investigations which proved this same
organism to be associated with one of the most fatal of the acute
infectious diseases in man, forecast the wide distribution which this
organism is now known to possess: The fact that pneumococcus may
vegeta�e as a harmless saprophyte in the mouth secretions of normal
persons, and that this same organism may give rise to severe and
fatal infections in man is also foretold in the early history of its dis
covery." Subsequent work by numerous investigators has abundantly
con:firmed this curious paradox, but the faterpretation of its signifi
cance in the epidemiology and specific therapy of pneumonia has been
made possible only by the recognition of the biologic relationships of
pneumococci by means of immunity reactions.
Morphology and Cultural and Other Biologic Characteristics.

Morphology.-Pneumococcus is a Gram-positive coccus which in
the exudates of infected animals and on artificial media is typically a
lance-shaped diplococcus. Variations in the size and form of the
cocci may be noticed, however, in different cultures and even in the
individual organisms present in the sam� culture. Oval, round, and
9
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elongated bacillary forms may occur. In young, actively growing
broth cultures of pneumococcus, ch?,in formation is common, while in
the same culture, after 18 hours' incubation, the organisms are usu
ally arranged in pairs with only an occasional short chain. In older
cultures of pneumoco'ccus, the organisms often appear Gram-negative,
swollen, with degenerated and involuted forms, resulting from disin
tegration and death of the cells. Pneumococcus is readily stained
by all the usual aniline dyes. It possesses no flagella, is non-motile,
and does not form spores. Capsules are easily demonstrable in
animal exudates and, by appropriate methods, may be found in
cultures from media enriched with blood or serum. The capsular
substance is most marked in recently isolated virulent strains, and is
readily lost on prolonged cultivation. In Pneumococcus mucosus,
Type III, the capsule is so pronounced as to be frequently demon
strable by Gram's stain, by which method it appears as a negatively
staining halo about the Gram-positive cell body. The exact signifi
cance of the capsule of pneumococcus is not known. That it may
serve as a protective mechanism of the organism and that it may in
some way be related to virulence, is suggested by the fact that cap
sular development is always much more marked when the organism
is grown in animal tissues in which presumptively there is some
opposition to its development. Study of a large number of strains
of pneumococci shows that there are average differences in capsular
development between Types I, II,.III, and IV (page 17). Although
in some strains of Type IV pneumococci capsular formation is well
marked, in others it is quite irregular and at times impossible to
demonstrate, even under the most favorable conditions. Type I
pneumococci usually show well formed capsules, and in Type II pneu
mococci the capsules are quite easily demonstrable and are generally
somewhat larger and den;;er than in Type I. In Type I II pneumo
cocci capsules are always well developed, are very large in compari
son with the size of the organisms, and may appear as voh.;minous
envelopes about the cell bodies. In our experience the amount of
capsular development seems to parallel the virulence of these organ
isms for man, as measured by the mortality occasioned by the dif
ferent types in human infectioj, In addition, it seems to be true
that the greater the amount of capsular development, the less the
amount ?f passive protection afforded by immune serum.
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Cultural Characteristics.-While growth may be obtained on the
usual simple media, pneumococcus is, nevertheless, sensitive to
slight variation in composition and reaction of the media. On media
prepared from meat extract, growth is irregular and at best sparse
and delicate. The pneumococcus colony on the surface of meat in
fusion agar, which has been enriched by the addition of a small
amount of sterile de:fibrinated rabbit blood, presents certain charac
teristic features. The colony is small, moist, translucent, discrete,
and round, with well defined edges, greenish in color, with a checker
like or ringed topography. The colony is finely granular, with a
darker center, surrounded by lighter ringed areas. Pneumococcus
on blood media produces a greenish zone of discoloration about the
colonies.
In broth pneumococcus grows diffusely, producing a uniform tur
bidity without pellicle and with a slight flocculent sediment. The
turbidity of broth cultures begins to clear up af�er 24 hours' incuba
tion, corresponding to the period of beginning autolysis and the
passing into solution of the disintegrating bacterial protein.
Gelatin is not liquefied; this medium, however, is not well adapted
for the cultivation of pneumococcus, since no growth of this organism
occurs at temperatures below 25 °C.
In milk and inulin serum water pneumococcus produces acid and
coagulation of the medium. Inulin fermentation by pneumococcus
is of differential value in distinguishing this organism from strepto
coccus. In studying the fermentation of inulin by pneurnococcus,
various irregularities are encountered. Although fermentation-is the
rule, it is not uncommon to find stra4ts that fail to ferment this
carbohydrate, and, in addition, the same strain may ferment it at
one time, and fail to ferment it at another. The failure to ferment
inulin in many instances may be due to the fact that not all prepara'
tions of inulin are fermentable by pneurnococcus, and not infrequently
different lots of media, prepared fr9m the same inulin, vary in their
suitability for growth. Therefore, while inulin fermentation is of
value in differential diagnosis of pneumococcus from other organ
isms, this reaction should be considered only as confirmatory evidence.
The addition pf simple carbohydrates to culture media enhances
the initial growth ,o( pneumococcus. However, the amount of acid
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formed by pneumococcus in sugar-containing media quickly reaches
a point at which growth is inhibited and the organisms rapidly die
in the products of their own metabolism. Fermentativ� reactions of
certain bacteria on selective carbohydrate have, in some instances,
furnished a basis for differential classification. A study of a large
number of strains of pneumococcus of known types on a series of
different carbohydrates has so far failed to show any fermentative
reaction which would afford a biochemic differentiation corresponding
to the immunologic classification of the four types of pneumococcus.
Temperat,u,re and Oxygen Requirements.-Pneumococcus is not sen
sitive in its oxygen requirement, and growth occurs equally weJl
under aerobic and anaerobic conditions. The optimum temperature
for cultivation is 37 ° C., the limits of temperature range being 2541 0C. The thermal death-point of pneumococcus as determined by
Sternberg is 52°C. for 10 minutes. The viability of pneumococcus on
artificial media is relatively short. It has long been a matter of com
ment that even on suitable meclium of proper reaction pneumococcus
sometimes fails to grow. This is especially common when an attempt
is made to grow the pneumococcus in meat infusion broth. Jn making
transfers from broth to broth it is usually necessary to increase the
amount of inoculum in proportion to the amount of broth in which
the organism is to be grown (R36) .1 The usual amount of culture
that it is ne�essary to transfer in order to insure growth is about 0.1
cc. to 5 cc. of broth. It is usually easy to start growth in broth if
the inoculation is made from infected blood. A loop of heart's blood
of a mouse dead of pneumococcus septicemia often suffices to initiate
growth in large amounts of broth, and always succeeds in amounts of
5 to 25 cc. of the 'U].edium. On the other hand, the transfer from
broth to broth of pneumococcus recently isolated is more difficult
and usually requires a considerably larger inoculation. As a strain
becomes accustomed to growth in broth, reinoculations into this me
dium grow with more regularity, although always requiring the
relatively large inoculum already referred to. Chesney (2) has shown
that transfers of pneumococcus made during the period of maximum
rate of growth grow readi]y and without the latent period of de1 R before reference numbers indicates that th� title appears among the
papers by the Staff of the Hospital of The Rockefeller Institute (page 106).
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veloprnent which is characteristic of older cultures. Kirkbride (6)
has further shown that when transfers in broth are made at 8 hour ·
intervals, pneumococcus maintains its· animal virulence for long
periods of time, whereas cultures'made at 24 hour periods rapidly lose
their virulence.
Viability.-The addition of defi.brinated.rabbjt blood to media not
only enhances the growth of pneumococcus, but prolongs the life of
the culture. Cultures of pneumococcus in blood broth preserved in
the ice box remain viable for several weeks. One of the best methods
for preserving pneumococcus cultures is that devised by Heim (5),
by storing the dried spleens of infected mice. At the time of autopsy
the spleen of the infected mouse is . removed and transferred to a
small sterile glass tube. The infected organ is quickly dried in
vacuum and the desiccated tissue kept sealed in the cold, unexposed
to light. Pneumococcus thus preserved maintains its viability and
virulence for months. The culture may be recovered by grinding up
the desiccated spleen in a sterile mortar with a little broth and in
jecting the organ emulsion intraperitoneally into a mouse, from
which the pneumococcus can in turn be recovered in culture. In
selecting spleens for preservation, care should be taken to choose
those from animals in which no mouse typhoid infection exists.
Mouse typhoid is a common infection in mice, frequently responsible
for the death of large numbers when it becomes widespread. Mice
which are apparently healthy frequently carry the bacillus of mouse
typhoid in the intestine, and when· these animals are experimentally
infected with pneumococcus, the typhoid organism becomes active
and invades the blood, tissues, and body cavities. It is difficult to
obtain pure cultures of pneumococcus from such mice because of the
rapidity and vigor with which Bacillus typhi murium grows on arti
ficial media, and because of its great virulence for these animals.
Bile Reaction.-Neufeld (13) first observed the fact that pneumo
coccus in the presence of bile und,ergoes solution. Bile solubility is
now recognized as a ·distinctive biologic character of pneumococ'cus,
and serves to differentiate it from closely allied organisms, such as
streptococcus. The active substance responsible for the lytic action
of bile on pneumococcus is cholic acid. In carrying out the test,
whole bile or 10 per cent solution of so�um taurocholate or sodium
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glycocholate in physiologic salt solution may be used.1 One-fifth to
one-tenth volume of bile will cause solution of an actively growing
broth culture of pneumococcus. Heat-killed pneumococci lose their
bile solubility. The presence of serwn in pneumococcus cultures
inhibits or completely arrests the lytic action of bile. Neufeld
reports the insolubility of certain avirulent strains of pneumococcus.
This phenomenon of insolubility, however, must be comparatively
rare, since among several hundred strains of pneumococcus isolated
by us from lobar pnewnonia, none has failed to be dissolved by bile.
In the diagnosis, then, of virulent pneumococcus, considerable reliance
may be placed on the bile reaction.
Virulence.-The virulence of pneumococcus is variable; it is attenu
ated by prolonged cultivation on artificial media, and increased by
animal passage. The virulence of pneumococcus for one animal
species does not necessarily imply similar invasiveness for the
tissues of another. Pneumococcus recovered from lesions in man
does not invariably possess increased virulence for susceptible ani
mals. Pneumococci isolated from the blood of pneumonia patients, as
a rule, are of such virulence that 0.000001 cc. of broth culture kills
white mice in less than 36 hours. On the other hand, strains have
been recovered from the same source which possess only moderate
virulence, faili� to kill white mice in much larger doses. The study
of the virulence of pneumococcus isolated from the circulating blood
during lobar pneumonia indicates that in general the intoxication is
more severe and the prognosis graver, the greater the virulence of the
infecting pneumococcus. Sip.ce, however, virulence can only be ex
perimentally tested in a different species, and since the defensive
mechanism of the host is variable, no direct measure of virulence in
man is available. However, as will be shown later in the discussion
of the biologic types of pneumococci, infection with pneumococci of
the various types results in differences in mortality which are fairly
constant.
In addition to pneumonia, pneumococcus may give rise to inflam
mation of the upper respiratory tract and the accessory sinuses of the
nose. Infection of the middle ear and invasion of the meninges may
also be due to pneumococcus. Primary peritonitis of pneumococcus
origin may occur, especially in young children. Focal infections, as
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empyema, peritonitis, pericarditis, endocarditis, arthritis, and lung
abscess due to pneumococci, may occur as sequelre of pneumonia.
Toxin Production.-Pneumococcus is a highly pathogenic micro
organism which is not known to secrete a soluble toxin, and whose
harmful effects are supposed to be due either to the setting free of
intracellul�r toxins, or to toxic split products formed by the disinte
gration of bacterial protein (R28), or possibly directly to the meta
bolic activities of the bacteria themselves (R29). When the bodies
of pneumococci are dissolved either by the action of bile salts, autoly
sis, or by alternate freezing and thawing, the resulting bacterial solu
tion is actively hemolytic for red blood corpuscles and is acutely
toxic for animals (R18, R23). Intravenous injection of such solp.tions
of pneumococcus produces death in rabbits and guinea pigs with acute
symptoms resembling those of anaphylactic death. The hemolytic
substance is thermolabile•and its activity is lost by passage through a
Berkefeld filter, and destroyed by proteolytic digestion with trypsin.
Both the hemolytic and toxic properties of this substance are influ
enced by the same measures, and the potency of both is to some
degree dependent upon the virulence of the pneumococcus f�om
which the substance is derived. The lytic action of the hemotoxin, as
well as its harmful effects in animals, may be inhibited by cholesterol
and partially neutralized by immune serum. Neutralization by anti
pneumococcic serum, however, is incomplete and not strictly specific.
Pneumococcus hemotoxin is not simply a product of autolysis, but
undoubtedly exists preformed in the bacterial cell as a hemolytic
endotoxin.
The production of methemoglobin by pneumococcus is another
phenomenon the occurrence of which may in some way be concerned
with the harm£ul effect of this organism in disease. The transfor
mation of hemoglobin into methemoglobin by pneumococcus occurs
only in the presence of free oxygen and the living bacterial cell.
Culture filtrates. and bacterial extracts of pneumococcus, when free
from living organisms, do not induce the methemoglobin reaction.
Precipitable Substance (R6, R7).-Pneumococcus during the early
stages of its growth forms a readily soluble substance which diffuses
into the culture medium in vitro, and in human and animal infections
is present in the �irculating blood, whence it passes through the kid-
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neys into the urine. This specific substance appears in the culture
medium in considerable amounts as soon as the pneumococci start
to grow. Its early presence is not attributable to the death and
subsequent disintegration of the bacterial cell, but it is due to the
extrusion into the medium of bacterial substance during the life
processes of the organism.
One of the chief points of interest in the discovery of the soluble
substance of pneumococcus is that it raises the question whether
this substance is in any way responsible for the intoxication which
attends pneumococcus infection. Studies to ascertain the answer
to this question are being carried on at the present time, but have
not y.et progressed to the point at which a definite answer can be
given. It may be said, however, that its toxicity is in no way com
parable with that of diphtheria toxin. On the other hand, it possesses
a degree of toxicity which, exhibited throughout the course of an in
fection, might account for the signs of intoxication in lobar pneumonia.
Differential Diagnosis.
' Although a differential diagnosis is not always simple, pneumococcus
possesses certain cardinal characteristics by virtue of which, in most
instances, it may be readily distinguished from closely allied organ
isms, as streptococcus. Pneumococcus is bile-soluble, possesses a
capsule, ferments inulin, is extremely pathogenic for mice, and on
blood agar forms a small, moist, fl.at, ringed, checker-like colony
with a greenish zone of methemoglobin about it. Moreover, as will
be discussed later, the various types of pneumococci react specifically
with their homologous immune sera. Streptococcus, on the other
hand, is not bile-soluble, does not ferment inulin, is less virulent for
mice; on blood media the colony is more opaque and raised, drier,
and more coarsely granular, without the surface markings or ringed
topography characteristic of pneumococcus, and is surrounded by a
zone of either hemolysis or green pigmentation.
Considerable confusion still exists in bacteriologic literature re
garding the identity of so called Pneumococcus muc.osus and Strepto
coccus mucosus. Pneumococcus mucosus, or Type III pneumococcus,
possesses the characteristics already described as typical of pneumo
coccus; it is bile-soluble, ferments inulin, possesses a voluminous cap-
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sule, is extremely virulent for mice, and produces greenish discolora
tion of blood media. Streptococcus m.ucosus, on the other hand, while
having a similar mucoid, heaped up, confluent colony, and possessing
a capsule, is, however, not bile-soluble, does not split inulin, is not
so pathogenic for mice, and has a greater tendency to produce hemo
lysis on blood agar. Finally, this organism, like other streptococci,
does not react specifically with Antipneumococcic Serum Type III.
Biologic Classification.
With recent advances in bacteriology and the knowledge gained
from attempts to apply the principles of bacterial immunity to human
disease has come the recognition of the fact that, in addition to the
grosser classification of bacteria, certain :finer characteristics exist
which serve to differentiate still further members of the same bac
terial species. Through the work of Neufeld (16) and his asso
ciates, it was demonstrated that all races of pneumococci are not
identical as far as their immunologic reactions are concerned. When
the study of pneumonia at the Hospital of The Rockefeller Institute
was undertaken, a large number of races of pneumococci from cases
of pneumonia was isolated and the immune reactions of these were
carefully studied (R33, R.20, R35). Animals were immunized to each
of these strains, and the immunity reactions of all of them to the
various immune sera so obtained were studied. Not only was th€
agglutinability of the various races in each of the sera determined,
but also the power of each of the sera to protect mice from infection
with each of the strains. The results of these studies revealed the in
teresting fact that pneumococci fall into two general classes. The
larger of these consists of pneumococci of Types I, II, and III, which
comprise about 80 per cent of aH strains encountered in disease, and
which represent three apparently fixed types ot' highly parasitic or
ganisms, each possessing common in,imunologic characters. Indi
vidual strains �f Type I and Type II are characterized by the pos
session of i�unity reactions common to all other members of the
homologous group. A number of variants of Type II pneumococcus
have been found (R4), a condition of considerable theoretic interest,
the practical importan9e of which, however, is not sufficiently great
to warrant detailed discussion here. Type III consists of Pneumo-
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coccus mucosus, an organism distinguished from other types by mor
phologic and cultural, as well as immunologic differences,, and related
to other strains of the same type by common immunologic reactions
(R38).
The smaller of these two main classes, which has been called T ype
IV, represents about 20 per cent of the strains isolated from cases of
lobar pneumonia, and is the type most frequently encountered in
the mouth secretions of normal individuals. Type IV pneumococci
possess greater heterogeneity and consist for the most part of indi
vidual strains which are not interrelated. As originally described,
this group was considered peculiar in that it seemed to comprise a
heterogeneous series of independent varieties, none of which ex
hibited immunity reactions common to the other types or to each
other. However, more recent study by Olmstead (19) of a large series
of strains of Pneumococcus Type IV has shown that this group may
contain smaller groups, the members of each one of which possess
certain characteristic immunologic properties. These studies of
Type IV pneumococcus are of interest and the results hold promise
of practical application. At present, however, the work has not
progressed to a point where practical use of it can be made, and hence
it would be premature to discuss this group from the standpoint of
specific therapy.
TABLE I.
Occurrence of Various Types of Pneumococcus in Lobar Pneumonia (454 Cases).
Pneumococcus
type.

I
II

II (atypical)*
III

IV

Incidence.

151
133
19
59
92

,e, ,enl

33.3
29.3
4.2
13.0
20.3

*The incidence of atypical Type II pneumococci has been determined only
during the last 2 years.

From Table I it is evident that Pneumococcus Type I is the most
common cause of infection in man, giving rise to about one-third of
the cases. Type II is next in frequency, and these two types together
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give rise to over 60 per cent of cases of lobar pneumonia, at least in
those localities in the United· States �n which studies of types of pneu
mococcus have �een made. Pneumococcus mucosus (Type III) gives
the lowest incidence in disease of the different types of pneumococcus.
Type IV is responsible for about 20 per cent of cases, although the
incidence of cases due to this organism seems to vary somewhat in
different localities.
The accuracy with which these types may be differentiated and
the constancy of their relative frequency in disease and health em
phasize the importance of their recognition in clinical and epi
demiologic studies. The exactness with which the large number of
strains studied has conformed to type indicates the extraordinary
uniformity and comparative fixity of the specific groups. These
distinctive differences in immunologic properties of pneumococcus
not only offer a reliable method for the more exact determination of
the. varieties of pneumococcus, but afford the only rational basis
for the study of the epidemiology and immunotherapy of pneumococcal
infections.
Culture Media and Staining Methods.

In the preparation of media suitable for growth of pneumococcus,
attention should be paid to the following points:
1. All media should be prepared directly from infusion of fresh
meat and not from beef extract.
2. Reaction of the media should be from 0.3 to 0.5 ·acid to
phenolphthalein.
3. In the sterilization of the media, care should be taken to avoid
excessive heating. Media should be �terilized by the Arnold method,
20 minut�s on 3 successive days, andshould not be autoclaved.
The following procedure has been found to give satisfactory results
in the preparation of broth and agar for cultivation of pneumococcus:
· Nutrient Broth and Agar.-1 pound 6£ lean chopped beef is allowed to infuse
in a liter of tap water over rught on ice. The unfiltered meat infusion is _boiled
for 30 minutes, filtered through paper, and the loss by evaporation made up by
the addition of water. 1 per cent peptone and 0.5 per cent sodium chloride are
now added. 1.5 per cent agar may be added at this point if agar is desired. The
mixture is allowed to boil for 2 minutes in the case
of broth, or, if for agar, until
°
the agar is dissolved. Titration to the neutral point with normal sodium PY·
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droxide is then carefully carried out. Media are then boiled for 6 or 7 minutes,
made up to volume, and filtered clear, and sterilized in the Arnold sterilizer for
20 minutes on 3 successive days. The media should finally titer 0.3 fo 0.5 acid
to phenolphthalein.
Blood Agar.-For enrichment purposes, the addition of a small amount of
sterile defibrinated rabbit blood to media prepared as above is recommended.
The addition of three or four drops of sterile blood to 4 or 5 cc. of agar or bouillon
serves as ample enrichment and provides most suitable medium for the growth
and preservation of pneumococcus cultures. Blood may be obtained either from
the ear vein of a rabbit or by direct heart puncture. Drawn directly into a
small sterile container with glass beads, the defibrinated blood can be preserved
for a week or more, and the method is, therefore, economical.
Serum Water Medium for Fermentation Tests.-For the· determination of
inulin fermentation by pneumococcus, the following medium devised by Hiss is
used, a positive reaction being indicated by the production of acid and the coagu
lation of the serum protein. Clear beef serum is added to 2 or 3 vo]umes of
distilled water. Heat the mixture for 15 minutes in an Arnold sterilizer at
100° C. to destroy ferments present in the serum. Add 5 per cent aqueous litmus
solution to a concentration of 1 per cent or an amount sufficient to give a deep
blue color. Add inulin to the serum water to a concentration of 1 per cent. The
inulin may be best sterilized by autoclaving at 15 pounds' pressure for 15 min
utes. Sterilize the inulin serum water by the fractional method, 100° C.
Preparation of Bile for Testing the Solubility of Pneumococcus.-Fresh ox bile,
obtained directly from the slaughter house, is autoclaved for 20 minutes, at 15
pounds' pressure. The bile is filtered to remove 'the precipitate formed on heat
ing and again autoclaved. The sterile bile is then ready for use. Heat does not
destroy the Iytic action of bile. While different samples of bile vary in their con
tent of the salts of cholic acid and hence in their ability to dissolve pneumococcus,
for routine purposes the bile reaction may be carried out by the addition of one
fifth to one-tenth volume of whole bile to plain broth culture of pneumococcus.
Stains for Pneumococcus. Gram's Stain (Sterling's Modiftcation).
Gentian violet . . ..... .. . . . ... . . . . . . . . . . . ..... .. . . . . . . . . ... 5 gm.
Alcohol, 95 per cent .......................................1 O cc.
Aniline oil ...... .... . . ......... .. .. .... .. .......... ... . . . . 2 "
Distilled water ............................................88 "
The aniline oil and alcohol are mixed by shaking, and the distilled water is
added. The genti� violet is ground in a mortar and the aniline solution
added while grinding. The solution is stable 3 to 4 months and stains rapidly.
Gram's Iodine Solution.Iodine... .. . . ..... . ... . .. .... .. .... .... . ... ... ........ . . . . 1 gm.
Potassium iodide............... . . . . . ... .. .... . .. ... ... . .. . 2 "
J?issolve in 20 cc. of distilled water. Add 300 cc. of distilled water.
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Safranin Counterstain.-10 per cent aqueous solution of a saturated alcoholic
solution of safranin.
Hiss' Capsule Stain.-Preparations, are best made by direct films from
pneumococcus exudates. Dry in air and fix by heat. Stain for a few seconds
with saturated alcoholic solution of fuchsin or gentian violet, 5 cc., in distilled
water, 95 cc. Flood the slide with the dye and hold the preparation for a
second over a free :flame until it steams. Wash off the dye with 20 per cent
aqueous copper sulfate solution. Blot; do not wash in water.
By this method the capsule appears as a faint blue halo around a dark purple
cell body. Better results may frequently be obtained by omitting heat fixation
and by washing off the dye with the copper sulfate solution as soon as it begins
to steam. Water should not be applied at any stage of the procedure.

ETIOLOGIC DIAGNOSIS.

If we possessed no methods for specific treatment or for instituting
specific preventive measures, the determination of the etiologic agent
in each individual case of lobar pneumonia would not be of great im
portance. However, since it is now known that certain cases of
pneumonia may be successfully treated with the serum of immune
animals, provided that the organism used in preparing the serum is
identical with that causing the infection, etiologic diagnosis becomes
imperative. Practical and quite rapid methods have now been de
vised for the detection of the organism causing the disease; even for
the differentiation of the specific types of pneumococci. This etio
logic diagnosis is, however, not only of importance in relation to
serum therapy, but has an important bearing on prognosis and is
essential for acquiring knowledge concerning the epidemiology of this
disease.
For the determination of the etiologic agent in cases due to other
organisms than pneumococcus, the same general methods are applica
ble as in cases due to pneumococcus. In certain cases, as those due
to FriedHtnder's bacillus, streptococcus, or staphylococcus, the micro
scopic examination of the sputum gives much information, and cul
tures of the sputum made on agar plates may show a great predomi
nance of the organisms causing the disease.. When the sputum from
these cases is inoculated into a mouse, as in the method about to be
described, these organisms outgrow the ordinary mouth saprophytes
just as do pneumococci. Blood cultures from the patient, when
positive, give, of course, clear evidence as to the nature of the
infection.
In the cases due to pneumococcus it is important not only to
_ determine that the infection is due to this bacterium, but it is also of
prime importance to determine the specific type of pneumococcus
cau_sing the infection, since treatment with serum is only applicable
in the cases due to Type I organisms.
· · The following is a description of the various procedures employed
in the isolation of pneumococci and.determination of the specific types:
22
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Isolation of Pneumococci.
that these methods may be of,
Organization of Laboratory.-In order
,
practical value, hospital and Board of Health laboratories should be
so organized, if possible, that diagnoses can be made at any time,
day or night. Arrangements for the rapid transmission of the speci
men of sputum to the laboratory are of great importance, since the
diagnosis must be made rapidly if the best results from serum therapy
are to be obtained. After a moderate amount of experience by the
laboratory worker, the method can be carried out with much rapidity,
.. especially where a number of diagnoses are to be made at the same
time; and where the work is properly organized, public health lab
oratories should not find that the introduction of this procedure
into their routine adds a great burden. For the actual carrying
out of the procedure, the co�paratively simple equipment of any
bacteriologic laboratory is sufficient. Facilities for the proper col
lection and microscopic examination of sputum, together with means
for its inoculation into mice, and the simple requirements for. mouse
autopsy and bacterial cultivation are all the equipment necessary.
Collection of Sputum.-Care should be exercised in the collection
of sputum to obtain a specimen from the deeper air passages, as free
as possible from saliva. This can be done in practically all cases,
even the most difficult, with a ]itt]e persistence. The sputum is col
lected in a sterile Esmarch dish, or other suitable container, and
should be sent at once to the laboratory for examination. When
delay is unavoidable, the specimen should be kept on ice during the
interval.
Microscopic Exq,mination of Sputum.-Direct films of sputum are
stained by Gram, by Ziehl-Neelsen, and by Hiss capsule stains.·
This serves to give an idea of the nature of the organisms present
· and an indication of the source of the sputum. Suitable lung speci
mens of sputum are relatively free, in most instances, from contami
nating mouth organisms. It is frequently possible to identify Type
III (Pneumococcus mucosus) organisms when they are present, as
they possess very large, distinct capsules, staining by both Gram's
and Hiss' methods.
Mouse Inoculation.-A small portion of the sputum, about the size
of a bean, is selected and washed through three or four changes of
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sterile salt solution in sterile Esmarch or Petri dishes to remove sur
face contaminations. When the sputum is too friable or when the
specimen is relatively free from secondary organisms, �his washing
process may be omitted. In either event, the kernel of sputum se
lected is transferred to a sterile mortar, ground up, and emulsified
with about 1 cc. of sterile bouillon or salt solution, added drop by
drop, until a homogeneous emulsion is obtained that will readily pass
through the needle of a small syringe. With a sterile syringe 0.5 to
1 cc. of this emuls,ion is inoculated intraperitoneally into a white
mouse (Figs. 1, 2, and 3). The pneumococcus grows rapidly in the
mouse peritoneum, while the majority of other organisms rapidly die
off, with the exception of Friedlander's bacillus, Bacillus influenz<.e, and
occasionally Micrococcus catarrhalis, staphylococcus, and strepto
coccus. Pneumococcal invasion of the blood stream also occurs early.
Bacillus influenz<.e, if present, likewise invades the blood stream;
other organisms, as a rule, do not. The time elapsing before there is
sufficient growth of pneumococcus in the mouse peritoneum for the
-satisfactory determination of type varies with the individual case,
depending upon the abundance of pneumococci in the specimen of
sputum and the virulence and invasiveness of the strain present.
It may be from 5 to 24 hours, averaging 6 to 8 hours with the para
sitic fixed types I, II, and III. As soon as the injected mouse
appears sick, a drop of peritoneal exudate is removed by means of
peritoneal puncture with a sterile capillary pipette, spread on a slide>
stained by Gram's method, and examined microscopically to deter
mine whether there is an abundant growth of pneumococcus present.
If there is an abundant growth of pneumococcus alone > the mouse is
killed and the determination of type proceeded with. If the growth
is only moderate, or if other organisms are present in any quantity,
further time must be allowed until subsequent examination of the·
peritoneal exudate shows an abundant growth of pneumococcus. It
should be emphasized that undue haste in killing the mouse is time
lost in the end.
Mouse Autopsy (Fig. 4).-As soon as the mouse is killed or dies,
the peritoneal cavity is opened with sterile precautions and cultures
are made from the exudate in plain broth and on one-half of a blood
agar plate. Films are made and stained for microscopic examination
by Gram's stain and Hiss' capsule stain. The peritoneal exudate
is then washed out by means of a sterile glass pipette with 4 to 5 cc.
of sterile salt solution, the washings being p]aced in a centrifuge tube.
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Cultures are then made from the heart's blood in plain broth and on
the other half of the blood agar plate.
Determination of Types of Pneumococcus.
Agglutination Metltod.-When the pneumococcus is present in
pure culture in the peritoneal exudate, the determination of type may
satisfactorily be made by macroscopic agglutination tests, as follows:
The peritoneal washings are centrifuged at low speed for a few min
utes until the cells and fibrin contained in the exudate are thrown
down. The supernatant bacterial suspension is transferred into a
second centrifuge tube and centrifuged at high speed until the or
ganisms are thrown out. The supernatant fluid is discarded and the
bacterial sediment taken up in sufficient salt solution to make a
moderately heavy suspension. The concentration of bacteria should
be similar to that of a good 18 hour broth culture of pneumococcus.
This suspension is used directly for macroscopic agglutination tests,
being mixed with dilutions of immune serum in small test-tubes in
equal quantities of 0.5 cc. each.
To obviate the difficulty that occasionally arises from the occur
rence of Type IV strains that show cross agglutination in all three
immune sera, the optimum dilutions of serum and the optimum in
cubation time that will surely identify all type strains and fail to give
any cross agglutination reactions, have been determined on a large
series of strains.2 The results are shown in Table IL
TABLE II.
Determination of Pneumococcus Types by Agglutination.
Poeumococcus
suspension O .5 cc.

Serum I
(1: 20)
o.s cc.

Type I......... ......... ·····
II. .....................

++

,,

Subgroups Ila, b, x............

Type III .....................
" IV.....................

-

-

-

-

Serum lI
(undiluted)
0.5 cc.

Serum II

Serum III

0.5 cc.

0.5 CC,

++
+

++

-

-

,

(1 :20)

-

(1 :S)

--

-

++

Incubation for 1 hour at 37 °C.
2 The dilutions of immune �erum indicated in both· the agglutinin and pre
cipitin tests refer only to the antipneumococcic serum in use a� the Ho�p�tal of
_
The Rockefcller Institute. As various lots of serum may differ m agglutmm and
precipitin content, the concentration of serum required to assure specificity of
reaction may vary somewhat from the figures given in Tables II and III.

26

ACUTE LOBAR PNEUMONIA

From Table II it will be seen that a 1: 20 dilution of Type I serum,
making, with the addition of an equal amount of pneumococcus sus
pension, a final dilution of 1: 40,· a 1: 20 dilution of Type II serum,
making a final dilution of 1: 40, and a 1: 5 dilution of Typ e Ill
serum, making a final dilution of 1: 10, serve to agglutinate Types I,
' II, and III pneumococci respectively and fail to show any cross
agglutination reaction with strains belonging to Type IV. It will
further be seen that with 0.5 cc. of undiluted Type II serum, as well
as with the 1: 20 dilution, pneumococci belonging to the various sub
groups of Type II may be identified- and rapidly differentiated from
Type II pneumococcus, in that they sho-yv partial to complete agglu
tination in undiluted Type II serum only, but not in the 1: 20 dilu
tion at the end of 1 hour's incubation at 37° C. For the determina
tion of types of pneumococcus in the peritoneal washings, these
serum dilutions give the most satisfactory and clear-cut results.
Five small test-tubes are set up as follows:
Tube 1.
" 2.
" 3.
" 4.
" 5.

+ 0. 5 cc. bacterial suspension.
0.5 cc. Serum I (1: 20)
"
"
"
II (undiluted) + 0. 5 "
0. 5 "
"
0.5 "
"
+ 0.5 "
II (1: 20)
"
"
"
+ 0.5 "
" III (1: 5)
0.5 "
"
"
+ 0.4 "
0.1 "sterile ox_bile

Tube 5, containing bile plus bacterial suspension, is for the determi
nation of the bile solubility of the strain and for the differentiation of
pneumococcus from streptococcus. The tubes are incubated in .the
water bath for 1 hour at 37 °C. Agglutination of Pneumococcus Types
I, II, and III occurs promptly in these serum dilutions and is specific.
Rapid clumping of the organisms is seen to take place and may be
brought out clearly by gentle agitation of the tubes. For the iden
tification· of atypical Type II pneumococcus, incubation is neces
sary, these strains showing partial to atypical agglutination in un
diluted Type II serum at the end of 1 hour's incubation. If no
agglutination occurs in any of the serum tubes and the organism is
bile-soluble, it is classified as Type IV pneumococcus.
Precipitin Method.-The determination <?f. pneumococcus types by
macroscopic agglutination tes�s with the peritoneal washings is inter
. fered with when other organisms are present in considerable num
bers, as occasionally happens, and consequently a delay of 18 hours
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or more may occur before the type of pneumococcus present can be
established. To obviate this, Blake (R9) has devised the following
method: It has been shown that pneumococcus during the period of
active growth in broth cultures produces a soluble substance which
gives a specific precipitin reaction with homologous antipneumococcic
serum. The method described by Blake is dependent upon this
,phenomenon. The peritoneal exuda.te is washed out with 4 to 5 cc.
of sterile salt solution in the manner already described under the
agglutination method, and the peritoneal washings containing cells,
fibrin, and bacteria are immediately centrifuged at high speed until the
supernatant fluid is water-clear. The supernatant fluid is then
pipetted off with care not to disturb the sediment, and is mixed in
quantities of 0.5 cc. each with equal amounts of antipneumococcic
serum in a series of small test-tubes as follows:
Tube L
" 2.
" 3.
" 4.

0.5 cc. Serum I (1: 10)
+ 0.5 cc. supernatant peritoneal washings.
"
"
"
0.5 " "
II (undiluted) + 0.5 "
"
"
"
"
0.5 "
+ 0.5 "
II (1: 10)
+ 0.5 "
"
"
"
0.5 " " III (1: 5)

An immediate specific precipitin reaction occurs in the tube contain
ing homologous immune serum, the other tubes remaining clear (Table
III). Incubation is usually not necessary. Two tubes of Type II
serum are used for the purpose of distinguishing between Type II
pneumococcus and members of its subgroups, the former giving a
precipitin reaction in both tubes, the latter only in the undiluted
Type II serum. A negative reaction in all serum tubes indicates
pneumococcm; belonging to Type IV. The precipitin method has
been tested with a large number of strains and has beeh consistently
positive and speci:fi..c with Pneumococcus Types I, II, and III, and
consistently negative with Type IV. The presence of other organ
isms, together with pneumococcus, in the peritoneal exudate does
not interfere with the reaction, and other microorgapisms than
pneumococcus produce no substance,that might give a false positive
reaction.
The results with Subgroup II pneumococcus have not been so satis
factory. Reference to Table III will show that pneumococci belong
ing in these subgroups give a precipitin reaction with undiluted Type
II serum, but not with the 1: 10 dilution, thereby being distinguished
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TA13LE III.

.

Determination of Pneumococcus Types by the Precipitin Method.
Supernatant peritoneal
washings 0.5 cc.

Type I.......................
". Il........... : ..........
Subgroups Ila, b, x . ..........
Type III., ..................
" IV.....................

Serum I

Serum II

(1: 10)
0.5 cc.

(undiluted)
o.s cc.

++

-

-

++
+

-

Serum II
(1: 10)
0.5 cc.

-

++

---

Serum Ill
(1: 5)

0.5 cc.

-

++
-

from typical Pneumococcus Type IL A number of Subgroup II
organisms, however, have been encountered in which the peritoneal
washings have_ failed to give a precipitin reaction with undiluted
Type II serum. In the identification of the fixed parasitic types of
pneumococcus, this occasional difficulty is of little practical impor
tance from the point of view of treatment, as there is at present no
specific therapy for cases of pneumonia due to organisms of ·these
types. For purposes of classification and statistics, these organisms
can be readily identified subsequently when pure cultures have been
obtained.
Confirmation of Types.-The determination of the type of pneu
mococcus by examination of the peritoneal washings should be con
firmed by macroscopic agglutination tests with a pure bouillon cul
ture of pneumococcus obtained from the heart's blood at the time of
mouse autopsy. The tec1mique is the same as that employed in the
agglutination tests on the bacterial suspension obtained from the
peritoneal washings. A test for bile solubility should also be made.

Determination of Type III Pneumococcus by Morphologic and
Cultural Characteristics.
Of the four types of pneumococcus, the third type, Pneumococcus
mucosus, is the only one which can be identified in most instances by
morphologic and cultural differences. Pn_eumococcus mucosus is
usually somewhat larger, rounder, and less lanceolate than other
types of pneumococcus. It possesses a large distinct capsule which
stains readily with Hiss' capsule stain and which usually retains the
pink counterstain with Gram's method. The peritoneal exudate
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of a mouse infected with this organism is usually quite mucoid and
.sticky, and the colonies on blood media are moist, mucoid, and con
:fluent. Occasional strains, however, are encountered in which
these characteristics are not so well marked and wh'.ich · are not so
easily distinguishable by cultural or morphologic differences from
other types. Furthermore, Pneumococcus Type II occasionally ex
hibits fairly well defined mucoid characteristics. For these reasons
the identification of Type III pneumococcus by morphologic and
-cultural characteristics is not always absolute, and the diagnosis
�hould be established by immunologic methods, when Type III
·serum is available.
Determination of Types of Pneumococcus in Blood Cultures, Spinal
Fluifl,S, Empyema Fluids, and by Lung Puncture.
Blood Culture.-From a positive bouillon blood culture, 10 cc. are
removed by pipette and centrifuged at lo'V-{ speed to remove the
. blood cells. The supernatant fluid is pipetted off and the bacteria
are thrown down by centrifuging at high speed. The supernatant
fluid is discarded and the bacterial sedime?,t resuspended in sterile
.salt solution. The type of pneumococcus is then determined by
macroscopic agglutination tests following the technique described
above.
Spinal Fluids and Empyema Flitids.-Cultures are made by the
methods ordinarily employed in culturing these fluids, and the type of
pneumococcus is determined by the agglutination method, with the
same technique as that applied _to blood cultures. If desired, in
addition to culturing the fluids, a portion may be centrifuged at
high speed to throw down the pneumococci present, and the bac
terial residue may be taken up in 1 cc. of sterile salt solution and
inoculated intraperitoneally into a mouse.
Lung P,uncture.-This procedure should be resorted to only when it
is impossible to obtain a suitc!.ble specimen of sputum or a positive
blood culture. In our experience this procedure is necessary only on
rare occasions. Cultures of the material obtained by puncture are
made in bouillon, and the determination of type is made by the
same technique as that employed in the case of blood cultures.
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Determination of Types of Pneumococcus by Means of Specific Pre
cipitin Reaction in the Urine.
The fact has been mentioned that a certain percentage of patients
suffering from lobar pneumonia excrete in their urine at some
stage of the disease a soluble substance of pneumococcus origin.
This substance gives a specific precipitin reaction with antipneumo
coccic serum corresponding in type to the organism with which the
individual is infected. A study of 111 cases of lobar pneumonia and
closely related respiratory diseases has shown that in 65 per cent of the
cases of pneumonia due to Pneumococcus Types I, II, and III, this
substance is present in the urine and can be detected by means of the
appropriate antipneumococcic serum. The reaction is spedfic for
the type of ·pneumococcus with which the individual is infected,·
and in no instance of respiratory disease due to organisms other than
pneumococcus has a positive reaction been obtained. The soluble
substance may appear ,in the urine at as early a period as 12 hours
after the initial chill, or it may appear for the first time at a later
stage of the disease. It may continue to be excreted for many days
after recovery h� occurre_d. It is the rule to find this substance in the
urine when pneumococcus septicemia exists. Examination of the.
urine for the presence of this substance has proven of some value for
the rapid determination of the type of pneumococcus with which the
individual is infected. Methods for the performance of the precipitin
test are therefore given in detail. This test, however, should not sup
plant the usual bacteriologic metho�s for the differential diagnosis of
pneumococcus types, but is useful in that in a certain percentage of
instances an immediate diagnosis can be made from an examination
of the urine.
Method Using Unconcentrated Urine.-A specimen of urine is ob
tained as soon as possible and cleared by centrifuging. The clear
urine is mixed in quantities of 0.5 cc. each with equal amounts of
antipneumococcic serum of the different types in a series ,of agglu
tination tubes (Table IV).
The strength of the reaction may vary from an almost impercep
tible cloud to a heavy flocculent precipitate. The reaction may occur
in some instances imID:ediately on the mixing of urine and serum, or
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TABLE IV.

Determination of Pneumococcus '.f'ypes by Precipitin Reaction in Urine.
0.5 cc. urine from:

I pneumonia....... , .............. .
"
II
"
" III

Type
H

"

IV

"

Serum I
o.s cc.

+

Serum 11
0.5 cc.

+

Serum Ill
0,5 CC,

+

may require incubation in the water bath at 37 °C. for 1 hour. Pro
longed incubation, however, must be avoided, since bacterial growth
under such conditions may obscure the test. In the precipitin reac
tion it is essential that all the reagents used, including the immune
sera, should be water-clear. In case the reaction is negative or so
faint as to be indecisive with the whole urine, the following method
of concentrating the urine may be employed:
Concentration of Urine for Precipitin Test.-25 cc. or more of a 24
hour specimen of urine, with the addition of a few drops of acetic acid,
are boiled down to a volume of about � cc., filtered through paper to
remove any precipitate of albumin that may occur, and the filtrate is
added to 8 to 10 volumes of 95 per cent alcohol. The precipitate
which forms is collected by centrifuging, rapidly dried to remove the
excess of alcoh9l, and the residue extracted with 2 to 3 cc. of salt so
lution, which redissolves the specific substance. Any undissolved
material is removed by centrifuging and the clear salt solution ex
tract is used for the precipitin test, as shown in Table IV.

LABORATORY AIDS IN PROGNOSIS.

Accurate prognosis in such an acute disease and one of such short
duratio� as lobar pneumonia is very difficult. That the clinical pie-·
ture may pass in the brief period of 24 hours from one that is ap
parently favorable to one of extreme urgency is a common obser
vation. In the early stages of the disease it is almost impossible from
the clinical picture alone to predict the outcome, and even in cases ·
·ending fatally, it is frequently difficult, even during the last days, to
say wh'1tt the result will be.
In the course of the studies on lobar pneumonia at the Hospital of
The Rockefeller Institute some facts have been determined which
are of value in estimating the probable severity of any case of
pneumonia, and in predicting the result. Studies of the bacteriology
-0f a large series of cases of lobar pneumonia have shown that the
type of pneumococcus with which the individual is infected plays a
part of considerable importance in the probable outcome of the dis
ease. In spite of certain reports to the contrary, our experience has
led us to believe that the presence of pneumococcus in the blood
during lobar pneumonia indicates a severe infection and is of bad prog
nostic import. It has already been stated that during the course of
lobar pneumonia there appears in the urine a soluble substance of
pneumococcus origin. The quantity of this substance can be fol
lowed from day to day, and the amount excreted seems to be
directly proportional to the severity of the infection. In occasional
cases the blood picture is of value in forecasting the outcome of
the disease.
Relation of Type of Pneumococcus to Mortality.

A study of a large number of strains of pneumococcus and the out
come of the disease in individuals infected with these strains has
shown that the different types of pneumococcus vary in their viru
lence for man. In Table V are shown the percentage incidence of the
di:fferent types of pneumococci in 100 cases of lobar pneumonia and
the average mortality in those untreated with serum.
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TABLE V.
Incidence of Various Types of Pneumococcus and Resulting Mortatity.
Type of pneumococcus.

I
II

III
IV

Incidence.

per cent

33
31
12
24

Mortality.

per cent

25
32
45
16

The statistics given in Table V approximate the facts as closely·
as they can be ascertained at the present time. Organisms of Type
. IV have in our experience been found to possess the lowest viru
lence of the different types for human beings. Type III pneumococcus,
although it is the cause of the smallest percentage of cases, never
theless gives rise to a high mortality, and the outlook for a patient
infected with Type _III prteumococcus is comparatively bad. Pneu
mococci of Types I and II are responsible for about 64 per cent of all
cases of lobar_ pneumonia and are of relatively high virulence for
man, the largest number of deaths in lobar pneumonia being due to
these organisms. The mortality in Type I infection is 25 per cent,
and in infectfons with Type II pneumococcus about 32 per cent.
These two types together are responsible for approximately 62 per
cent of all deaths from lobar pneumonia. It is evident, therefore,
that the outcome of any case of lobar pneumonia is influenced by the
type of organism with which the individual is infected, and knowledge
of the type of pneumococcus causing the infection is therefore of value
in prognosis. It must be borne in mind, however, that there is con
siderable variation in the severity of the individual cases due to the
different types of pneumococcus.
Specific Precipitin Reaction in the Urine.
In the course of our studies it has' been found that pneumococci
of Types I, II, and III during the active period of growth form a
soluble substance. Type III pneumococcus forms the largest amount
of this substance, Type II somewhat less, and Type I the least. The
elaboration of this substance by Type IV pneumococcus has not been
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studied because of lack of specific sera for this group. This soluble
substance is formed not ·only on artificial growth in vitro but also
during natural infection in man. In patients suffering from lobar
pneumonia this specific substance can sometimes be demonstrated
in the blood. It is, however, frequently present in the urine in
easily demonstrable amounts. The quantity of this substance pres
ent in the urine varies with the intensity of the infection and in-many
instances furnishes a basis for estimating the severity of the disease.
In Table VI are presented the relative frequency of occurrence of the
specific precipitin reaction in the urine during lobar pneumonia and
the outcome of the disease.in the cases studied.
TABLE VI.

Specific Precipitin Reaction in Urine in Lobar Pneumonia.
lncldcnec.
Type
•f pneumococc1,1s.

I
II
III

Mortality.

No. of
cases

No. of
cases Positive.
positive, negative.

20
20
12

15

8

5

Cases showing positive
reactions.
No.

,,., ,e,u

57.1
71.4
70.5

Died.

No.

per ,mt

. 20

20
12

2

10

7

Cases showing negatin
reaction...

10.0

50.0
58.3

15
8
5

Died.

0
0
1

per�,,.,

0
0
20

The urine from 80 cases of pneumonia due to Pneumococcus Types
I, II, and III was studied. In 28 of these the urine showed no reac
tion, and in 52, or 65 pe;r cent, the test was positive. The mortality
among the positive Type I cases was low, probably due to the fact
that all these cases were treated with specific antipneumococcic serum.
Of the 32 cases of Types II and III infection giving a positive urine
reaction, 17 died, a mortality of 53.1 per cent. Of 13 cases due to
Pneumococcus Types II and III having a negative reaction in the
urine, only one died, a mortality of 7.7 per cent.
Most of the cases which fail to show the precipitable :,ubstance
the
urine recover, whereas the mortality is high among cases in
in
which its presence is demonstrable. The preseµ.ce of specifically
precipitable substance in the urine during lobar pneumonia therefore
seems to indicate a severe infection. If the amount present in the
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urine increases from day to day, the outcome is usually· fatal unless
this result is prevented by th� administration · of antipneumococcic
serum.
Significance of Pneumococcus Septicemia.
The suggestion has been made that lobar pneumonia is primarily a
b:k>od infection, and that the local process in the lung is but part of a
generalized condition. This view has arisen from the discovety that
pneumococcus may at times appear in the circulating blood of persons
suffering from lobar pneumonia. Reports in recent years have varied
considerably as to the frequency with which it is possible to ob'tain
pneumococcus from the blood. Some observers have obtajned posi
tive cultures in from 20 to 50 per cent of cases examined and, since
these were the more severe cases, they think the.presence of pneumo
coccus in the blood is of bad prognostic import. Others, _claiming
more suitable technique, have found pneumococcus in the blood dur
ing lobar pneumonia with great constancy and attach very little
prognostic significance to its presence. In the cases of lobar pneu
monia studied in the Hospital of The Rockefeller Institute, pneumo
coccus has not been found in the blood in all instances: In those
cases in which a positive culture was obtained, the· course of the
infection has been invariably severe and in many instances the disease
terminated fatally.
In -Table VII are presented the results of blood cultures in a series
of 448 cases of lobar pneumonia at the Hospital of The Rockefeller
Institute.
TABLE VII.
Relation of Positive Blood Cultures to Mortality in Pneumonia.
Type

of pneumococcus.

Ill

IV

145
148
55
100

Total. .....

448

I
II

Mortality.

Blood cultures.

No. of
cases
examlned.

Positive.

so
I

Negative.

Cases with positive blood culture.

per ,wt

pu ,mt

per uni

per uni

Cases with nega,.
tive blood culture.

49
16
21

34.S
33.1
29.0
21.0

95
99
39
79

65.S
66.9
71,.0
79.0

13
36
16
11

26.0
73.4
100.0
52.3

11

3

3.1
9.0
28.2
3.8

136

30.3

312

69.7

76

55.8

26

8.3

3
9
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Examination of Table VII shows that of 448 cases of lobar pneu
monia, pneumococcus was obtained from the blood in 136 instances,
or 30.3 per cent. In spite of the apparently low percentage of positive
cultures in comparison with the statistics of some investigators, we
feel that this percentage is representative of the number of positive
blood cultures obtained by the ordinary hospital routine of taking ·one
or two blood cultures in each case of pneumonia. The taking of re
pea_ted blood cultures during the course of the disease would probably
raise this percentage. In 37 of these cases in which blood cultures
were made at frequent intervals, positive :findings were obtained in 50
per cent.
In the 136 cases with positive blood culture the mortality was 55.8
per cent, whereas in 312 cases with negative blood culture the mor
tality was but 8.3 per cent. These figures seem to show that the
presence of pneumococcus in the blood during lobar pneumonia
indicates a severe infection and is of bad prognostic significance.
The type of pneumococcus obtained from the blood has an impor
tant bearing on the outcome of the disease. · In 50 cases in which
Type I pneumococcus was obtained from the blood, the mortality
was 26 per cent. The fact that this figure is so low is undoubtedly
dependent upon the fact that a large number .of these cases was
treated with Antipneumococcic Serum Type I. Of 49 cases in which
Type II pneumococcus was obtained from the blood, the mortality
was 73.4 per cent. Of 16 cases in which Type III pneumococcus was
recovered from the blood, the mortality was 100 per cent. Of 21
cases in which Type IV pneumococcus was found in the blood, the
mortality was 52.3 per cent. These figures indicate that, with the
exception of infections with Type I pneumococcus, in which case
specific serum is efficacious, the more virulent the type of pneumo
coccus obtained from the blood, the less is the likelihood of recovery.
Our experience has been that the greater the number of colonies of
pneumococcus that �evelop from 1 cc. of blood when plat� cultures
are made, the more likely the disease is to have a fatal termination.
The following :figures indicate the significance of increas.ing numbers
of pneumococci per cc. of blood. The illustration is drawn from
our experience with plate cultures made from the blood of individuals
with Type II pneumococcus infections. Of 14 cases in which the
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numbers of colonies were from 1 to 15 per cc. of blood, 6 died, a mor
tality of 43 per cent; of 2 cases with 15 to 30 colonies per cc., 2 died;
of 4 cases with 30 to 75 colonies per cc., 4 died; of 16 cases with more
than 75 per cc., 16 died. It is thus seen that all cases of Type II
infection in which the number of colonies per cc. of blood was 15 or
more were fatal. This figure, of course, is not to be considered as
absolute, but �erves to show that cases of Type II infection with con
siderable numbers of pneumococci per cc. of blood are almost
invariably fatal. In some cases of lobar pneumonia, invasion of the
blood may occur as late as the 5th or 6th day. A number of these
cases are rapidly fatal and study of the blood has shown that the
· · numbers of pneumococci per cc. of blood increased with extraor
dinary rapidity, the number of colonies in many instances running
up into the thousands.
The study of these results leaves little doubt that invasi_on of
the blood by pneumococci in any type of lobar pneumonia is a
serious matter, that the seriousness of this invasion is propo!tional
to the virulence of the type of organism, and that the greater the
number of organisms present, the more likely is the disease to'have a
fatal outcome.
Technique of Blood Culture.-Under aseptic precautions 20 cc. of
blood .may be easily aspirated into a sterile Luer syringe from a
convenient vein, usually near the bend of the elbow of the patient.
The syringe may be sterilized by boiling for 20 minutes in a covered
receptacle, or sterilization may be accomplished by dry heat or the
autoclave, the syringe being enclosed in a large cotton-plugged test-.
tube. The latter method has the advantage of immediate avail
ability when cultures are to be taken. The needles used are prefer
ably nickeled steel needles of about No. 18 gauge_ The bevelled.
points should be sharpened each time before using, to insure ease in
penetrating the vein and to reduce the discomfort of the patient-to a
minimum. With nervous individ'qa}s or in those cases where small
veins or adipose tissue give promise of difficulty, the skin may be m·
filtrated with a little 1 per cent novocaine solution. Then, if any
trouble is experienced in piercing the vein, the proc�dure will at.
least be painless.
When the blood is obtained 10 cc. are added to a flask of 150 cc. of
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plain beef infusion broth (page 19) previously wanned 'to body tem
perature, and immediately incubated. The remainder of the blood is
added in varying amounts to melted plain agar cooled down to about
45 ° C., a.nd plates are made. Usually after 18 to 24 hours' incubation
at 37 °C ., if the broth culture is positive, the supernatant fluid be
comes diffusely turbid, and, on shaking, the mixture appears brownish
red to chocolate in color. If very few organisms are present, several
days may elapse before any change in the color of the cultures takes
place. Consequently broth cultures should be incubated for 7 days
a.nd subcultures made on blood agar slants before they are considered
sterile.
Colonies on the agar plates usually appear as small white dots,
surrounded frequently by a greenish black area due to methemoglobin
formation. Identification of the organisms obtained from the broth
a.nd agar cultures should be made by the methods described previously (page 29).

well

Leukocytosis.

known that lobar pneumonia is usually accompanied by an
It is
increase in the total number of leukocytes in the blood, as well as
by a relative and total increase in the percentage of polymorpho
nuclear cells. When such a leukocytosis is absent, it may �ean a
relatively mild infection or an overwhelming one. · Chatard (1), in an
analysis of 582 cases of pneumonia at the Johns Hopkins Hospital,
found a mortality of 55 to 60.per cent in 39 cases having a leukocyte
count under 10,000. With the rise in the number of leukocytes from
10,000 to 30,000 there was a progressive decrease in the mortality.
Similar experience has been derive.cl from obseryations of the leuko
cytes in 463 cases of lobar pneumonia in adults studied at the Hospital
· of The Rockefeller Institute. Table VIII shows the same striking
·increased mortality where the leukocytes were below 10,000 per cc.,
as found by Chatard, and a ·similar progressive fall in mortality with
increasing leukocytosis.
While a single observation of white blood cells may furnish infor
mation of prognostic value, a study of the variation in the num
ber and character of the leukocytes during the course of the dis
ease has revealed many points of interest. It has been· noted that
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TABLE VIII.

The Relation of Leukocytes to Mortality in Lobar Pneumonia.
Leukocytes.

No. of cases.

Under 10,000......................................... .
10,000-20,000........................................ .
20,000-30,000.........................................
30,000-40,000.........................................
40,000-50,000.........................................
Above 50,000..........................................

29
143
177
76
29
9

Total.............................................. .

463

Mortality.

per cenl
65.5

23.7

18.0
14.4

24.1

11.0

when conso�idation of the lobe or lobes is taking place or during the
period when a spread or infection of a new area of the lung is in
progress, there may be a well marked decrease in the number of
leukocytes. The following observations made on a patient having a
Type I pneumococcus infection are illustrative:
Day of disease.

2
3
4
5

Leukocyte
count.

15,600
13,700
11,200
8,100

Polymorpbon11clears.

Lymphocytes.

Large mononuclears.

per ,enl

per ,en/

per tent

97
89
94
-88

3
8
4
7

3

2
5

Temperat�re.

•p,

105

103.6
103.4
103.6

'

Lesion spreading from lower to upper lobe.
6
7

8

10

11

12
13
14

9,200

14,600
12,600
16,400
13,200
17,200
9,200
8,800

78
89
88
78
85
72
79
79

5
5
5
6
10
15

3

11

17

6

7
16
5
13
17
10

103
103.8
103.4
103
100
99.8
100.4
100.5

In this case a single observation made on the 5th and 6th days of
the disease during the spread of the lesion from the lower to the
upper lobe might have given one a false impression of the severity
of the process.
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A steady rise in the leukocyte count during the course of the
disease is usually of favorable import. The following case illustrates
this point:
Da.yof
disease.

Leukocyte
' count.

Polymorphonuclears.
pu,enl

4
5

6
7
8
10

12

9,400

9,400
13,600
14,400
14,500

18,700
20,000

14,400
12,000
9,000

8,800

93

96

87
88
86
94
86
84
85

78
68

Lympbo·
cytes.

Large mononuclears.

Transitionals.

Eoslnopbils.

Temper-

per ,e,11

pu,ml

pu cenl

,per ce11I

•p,

4

3

s

s

2
2

5
5
6

4
2

4
4

7

13

6
4

6
3

6

10

16

a.ture.

103.6
103.6
103.2

1

s

13

4

103.6
101.4

100.2
99.2

1
4
3

100

98.8
99.2

2

On the other hand, if an initial low leukocyte count ·shows little
or no tendency to rise even with specific treatment, the prognosis
may be grave. This is illustrated by tlie following case:
Day of disease.

Leukocyte count.

3

8,000
7,200

4
5

8,800

11,900

6

12,300

7

Died.

Tempenitu.re.
•p.

102.5

102.8
102.8
102.5
102

With the fall in temperature by crisis or lysis, the number of leuko
cytes in the blood rapidly falls in the uncomplicated cases. A con
tinuance of the high count, especially if accompanied by a continued
high percentage of polymorphonuclear cells, suggests a complication
with pus formation, most frequently empyema or otitis media. A
continued leukocytosis with diminishing polymorphonuclear cells and
corresponding rise in lymphocytic cells, with the presence of a few
eosinophils, suggests delayed resolution, or serum sickness if the case
has been treated with specific serum.
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, The appearance and staining qualities of the white blood _ cells
often reflect the condition of the patient. In those mortally infected,
in addition to an abnormally small number of leukocytes, there may
be a predominance of degenerated polymorp honuclear cells. The
nuclei of these cells appear fragmented, stain poorly, and the cyto
plasm presents an appearance suggesting cloudy swelling.
On the other hand, a day or two before crisis, together with the
increase in the total number of cells, there may appear many poly
morphonuclear cells which may be termed immature forms. The
nucleus is large and succulent in appearance and contains large
amounts of chromatin material. The cytoplasm of the cell is, in
addition, packed with well staining coarse granules. These minor
changes that take place in the white blood cells in the presence of an
infection, while of less practical value from the standpoint of prog
nosis than the information that may be derived from the deter
mination of the type of infecting organism, the presence or absence of
precipitable substance in the urine, or the occurrence of pneumococcus
in the blood, are nevertheless of considerable importance.

ANTIPNEUMOCOCCIC SERUM.

It was demonstrated as early as 1891 that animals such as the rabbit
can be rendered immune to lethal doses of pneumococci by the pre
vious injection of sublethal doses of the organisms or by the injec
tion of dead cultures. Furthermore, it was shown that the serum of
these immune animals is able to pr0tect .other animals against a fatal
infection, and even to cure them. after infection has once occurred,
provided that the injection of the serum is not too long delayed. It
is not surprising that attempts were at once made to apply these
fundamental facts to -the, treatment of lobar pneumonia in man.
The serum of horses immunized to pneumococci has been widely
employed in treatment (17, 20, 25,26, 32, 33), but the results obtained
have been inconclusive, and a few years a.go the concensus of the
best clinical opinion was that antipneumococcic serum was of little
or no value.
It must be remembered that most of these efforts to treat pneumonia
with immune serum were made before we had any knowledge concern
ing the immunologic differences between various ra;ces of pneumococci;
they were all considered identical. Moreover, at the time these at
tempts were made to employ immune serum, there were no methods
for accurate etiologic diagnosis in the individual cases, and the
serum was administered to all cases indiscriminately. It is little
wonder, therefore, that the results of treatment were unsatisfactory
and inconclusive. Moreover, the immune sera were employed in
small amounts and were injected subcutaneously.
We now know from experiments on animals that an antipneumo
coccic serum is only protective and curative provided it is employed
to combat an infection due to the same type of organism as that
used in its production. We also know that to cure after 'infection
has once occurred, the serum must be employed in very large amounts,
and preferably injected intravenously.
The discovery of these facts, together with the development of
methods for making an etiologic diagnosis in every case, made it
42
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advisable to undertake again the treatment of cases of pneumonia.
with the serum of horses immunized to the various specific types.
These attempts have resulted in the demonstration that antipneumo
coccic serum, prepared by the injection of Type I pneumococcus, is
highly effective in the treatment of cases of pneumonia due to the
same type of organism. The serum of Type II is much less effica
cious. Indeed, it has not yet been thoroughly demonstrared whether
it has any practical effect on the outcome of the disease or not.
Immune serum may be prepared by the injection of Type III pneumo
cocci and this serum has slight agglutinating power and slight protec
tive power for animals (30). This power, however, is so slight that the
therapeutic application of this serum has not been considered prom
ising or justifiable. From what has previously been stated it would
be impossible to prepare a serum which would be effective against
any considerable number of cases of infection due to Type IV
pneumococc1.
Production of Serum.

In spite of all that has been written concerning the theoretic prin
ciples involved in the preparation of antipneumococcic serum, and in
spite of all the reports of the therapeutic application of various sera
which have appeared, very little has been written concerning the
actual method of preparation of these sera. In general, they have
been prepared by the injection into horses at weekly intervals of
gradually increasing doses, first of dead, then of living pneumococci.
Based on certain experimental studies which 'have been carried on
in the Hospital of The Rockefeller Institute, this method of producing
the ser'l;lm has been modified, so that the time required has been
materially lessened (R31).
What is attempted in the production of 'immune serum is to obtain,
as rapidly as possible, a serum possessing the highe'st possible content
of the known antibodies, agglutinins and bacteriotropic substances,
and the highest possible protective action against pneumococcal jn
fection, as tested in mice. Whether such a serum meets all the theo
retic requirements is not at present our concern. Moreover, this
serum sh�uld be specific; that is, effective against the type of pneumo
coccus causing the infection. Up to the present time antipneumo-
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coccic serum has been demonstrated to be effective only in cases
due to Type I pneumococcus, so in our opinion the production of anti
pneumococcic serum for routine practical use should, for the present,
be confined to that prepared by the injection of this type of pneumo
coccus. At the present time the production of a polyva1ent anti
pneumococcic serum is not practical or important, as it is in the
case of the production of polyvalent meningococcic serum, for in
stance. The conditions as regards specificity among meningococci
are quite different from those obtaining among pneumococci. The
former organisms also differ among themselves in their immunity
reactions. However, they all possess certain common characters,
so that an immune serum against any one type has some action
against all meningococci. With pneumococci, at least as regards the
first three types, the immunity reactions are almost absolutely
specific. A Type I serum is hardly more effective against infection
due to Typ e II pneumococci than antidiphtheria serum would be.
For these reasons we do not advise the routine manufacture of
polyvalent antipneumococcic serum.
Concerning the size and spacing of doses, we have found from numer
ous experiments in rabbits that instead of the old method of weekly
injections, much better results are obtained if the injections of dead
organisms are made daily for a period of 7 days; then after another
period of 7 days elapses, a similar series of injections is made. It has
been proved that the doses should be small, as very large doses inhibit
the immunity response. After several series of injections of dead cul
ture, it may be necessary to employ the live bacteria. Here it is
well to take advantage of the observations of Fornet and Muller,
which have already been used by Flexner and his assistants in the
manufacture of antimeningitic and antidysenteric serum. In this
method the injections are made daily over a period of 3 days, deter
mining the size of the dose largely by the reaction obtained. The
following is a brief statement of the method of immunizs1,tion as
actually employed by us at present:
Technique of Immunizing Animals.-A sound, fairly heavy horse
should be chosen and quarantined until a glanders test is performed.
A specimen of blood obtained before any treatment is given is kept
as a control. The immunization is carried on as follows: All in-
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jections are made intravenously, employing for this purpose a Luer
syringe. To avoid any accidental injury to the vein it is weil
to have the needle attached to. the syringe with a small piece of
rubber tubing. The strain of pne'll:mococcus (living or dead) which
is used for injection should be one highly virulent for mice (0.000001
cc. kills regularly) and it should have had very few passages either
through animals or in artificial medium since removal from the
human patient. The method for keeping these cultures is described
above (page 13). In preparing the material for injection, both liv
ing and dead organisms, cultures are grown on beef peptone broth,
reaction 0.3 to 0.5 per cent acid to phenolphthalein. Cultures about
12 to 15 hours old are preferable, as at this time maximum growth is
present, with a minimum of autolysis. The cultures should contain
about 200 to 300 million bacteria per cc. The culture is centrifuged
until the supernatant fluid is clear. With the large centrifuge em
ployed by us this req�ires about 20 minutes to an hour. The super
natant fluid is then pipetted off and the sediment is taken up in a small
amount of sterile salt solution.
If living organism�- are to be injected, the emulsion in salt solu
tion is not made until just before injection, so that death and auto
lysis may not occur. If the organisms are to be injected dead, the
emulsion is heated in a water bath at 56° C. for half an hour. For the
daily injections a considerable amount of the vaccine is prepared as
above and kept on ice. This vaccine may be employed for all the
injections in one series of 6 to 7 days. We think, however, that a
fresh emulsion should be prepared for each new series. Of course the
emulsion of live bacteria should be freshly prepared for each injec
tion. The dilution of the injected fluid should be such that the
total volume is about 20 cc.
The following course of injections is now carried out: Every day for
6 days an injection of the emulsion containing bacteria from 50 cc. of
bouillon. culture is made. An interval of 7 days is allowed to elapse
and then a second series of daily injections of the same sized doses
is made. Again an interval is allowed to elapse and on the 6th
day a specimen of blood is obtained foT testing. Tests are made at
once for agglutinating and protective power. This requires several
days.
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If the serum causes agglutination in a dilution of 1: 200 and is of
standard protective value, that is, 0.2 cc. protects a mouse against 0.1
c�. of virulent culture, bleeding could be carried out at once (10th
to 12th day). As a matter of fact, we have never seen the titer of the
serum after this amount of treatment to be so high. Consequently
it has been our practice, 8 to 10 days after the last injection of the
second series of dead cultures, to commence injections of living bacteria.
Three injections are given on successive days. The temperature of
the horse is taken every 2 hours for 8 to 10 hours following each of
the injections of living bacteria. The first injection should contain the
bacteria from 2.5 c·c. of the original culture. If the temperature re
action following this injection is only moderate; not over 40.5°C., a
second injection of the bacteria from 5 cc. growth is given on the fol
lowing day. If the reaction from this is only moderate, the dose is
again doubled on the following day, the bacteria from 10 cc. of bouillon
being injected. It must be stated that as far a� pneumococci are con
cerned it is difficult to regulate the dosage entirely by the febrile re
action obtained. If the reaction is very severe, of course the dose is
made smaller than that mentioned. On the other hand, even though
the reaction is very slight, we do not advise giving more than the
amounts stated. 6 days after the last injection another specimen of
blood is obtained for testing. If the serum is of the standard strength,
bleeding can now be done. If, however, the potency is still too low, a
second series of injections of living bacteria is made. These injections,
unless there are reasons for modifying them, should consist of the bac
teria from ·20, 40, and 80 cc. of broth on the 3 days respectively.
Again, the size of the doses may need to be somewhat modified, on
account of the severity, or the lack, of febrile reaction. Most horses
will require still further injections of living cultures. In any case, we
think they should be made in series of three, given on successive days,
with 7 day intervals between the series. The third series in most
horses may consist of the bacteria from 100, 150 and 200 cc.. of broth.
From ou� present standpoint we believe that the size of an injection
should never exceed the bacteria from 300 to 400 cc. of broth. Fol
lowing the bleeding, it is well to allow the horse to remain quiet for
3 or 4 days. Then a series of three injections of living cultures,
50, 80, and 100 cc., is again given. After a week the serum is again
I'
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tested, and if of standard strength, bleeding may be done on the 10th
day. If the serum is not sufficiently s·trong, a second series of in
jections of living bacteria is given, 'again keeping the dosage fairly
small, never giving more than the bacteria from 300 to 400 cc., and
always bleeding about 10 days after tli.e last injection.
Technique of Obtaining Serum.-The bleeding of the horse usually takes place
about 10 days after the last injection of antigen. It is possibly well to allow the
horse to fast 12 to 18 hours before bleeding. The horse is then brushed thoroughly
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TEXT-FIG. 1. Bleeding jars.
and its coat washed down with a dilute lysol solution. The floor, walls, and
ceiling of the bleeding room are also washed down. The neck of the horse over
the external jugular vein is shaved, washed with alcohol, painted with tincture
of iodine, and anesthetized with a sterile 2 per cent solution of novocaine. The
skin over the vein is incised and the vein is punctured with a cannula bearing a
rubber tube, through which the blood is drawn into the receiving Jar. This
cannula is 8 cm. in length and 5 mm. in bore; the end of the cannula is bevelled
for 1.5 cm,, has a sharp point, and the bevel is turned against the blood stream.
The bleeding jar (Text-fig. 1) is of glass, cylindric in shape, open at the top, 28
cm. in height, and 16 cm. in diameter, a slight modification of the type of jar
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,described by Kraus and Levaditi (8); we have found "Nonex" glass very satis
factory. The jar bears a loosely fitting cover of tinned copper having an ec
,centric and a concentric opening; the former carries an ordinary cork through
which passes the glass,inflow tube (A), to which is connected the rubber tube from
the cannula; the inflow tube reaches about 1 inch below the cover. Suspended
1from the cover, when it is in position on the jar, is a flat octangular weight (B)
,of tinned copper, with an aperture through which the inflow tube passes. This
weight is 14.5 cm. in diameter and weighs about 700 gm. On the under surface
<>f the weight are four projecting points or teeth, about ½ inch in length, which
serve to prevent it from slipping off the clot when dropped. The weight is sus
pended in the jar by a loop of wire (C) which passes through the concentric open
ing in the cover. By means of a small piece of wood or metal (D) passed through
· this loop, the weight is held in position. This piece of wood acts as a trigger
which, when withdrawn, allows the weight to fall on the clot.
When the cover, weight, and inflow tube are in position on the jar, the whole
is covered by a layer of paper which is tied around the jar. Through the paper
the inflow tube is allowed to pr9,ject. On top 9f this, the inflow tube still pro
jecting, is placed a layer of cotton and another layer of paper, and these are tied
securely; a cotton cap enclosed in paper is now secured over the inflow tube.
A cord (E) attached to one end of the wooden support of the weight comes to
the exterior through the paper and cotton covers. The jar so prepared is steril
ized in the autoclave at 15 pounds' pressure for 20 minutes and afterwards dried
at 100°C. by dry heat. It is advisable to place a few cc. of water in the jar before
placing the latter in the autoclave.
Each jar is graduated and usually 3.5 liters of blood are drawn into each one.
The cannula and tube are sterilized by boiling for 20 minutes. The cannula
should have a sharp, cutting edge, which should be protected during sterilization
by wrapping the instrument in cotton. When the cannula is withdrawn from the
vein, usually no difficulty is experienced in stopping the blood flow, pressure and
perhaps a stitch in the skin being sufficient in most cases.
6 to 8 hours after the bleeding, when the dot is firm, the trigger supporting
the weight is released by pulling the attached cord (E); the weight then drops on
the clot and materially aids in expressing the serum. The serum is usually
drawn off the clot by syphonage about 40 hours after the bleeding, the short limb
of the syphon being introduced into the jar through the central opening (now free)
in the cover. The serum is syphoned into flasks of 6 liters' capacity. The long
limb of the syphon passes into the flask through a doubly perforated rubber cork.
Through the other perforation there passes a short cotton-plugged glass tube
through which partial exhaustion of the flask starts the syphon action. {::are
should be taken in the syphonage not to carry over particles of clot or cellular
debris. The serum is stored in these 6 liter flasks, sealed with rubber corks, and
capped with sterile tin-foil. The syphon and corks are sterilized by boiling and
the bottles (plugged with cotton and capped with paper) are sterilized in the
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autoclave and afterwards dried at 100° C. by dry heat. Usually at a single
bleeding 9 to 12 liters of blood are withdrawn and from this, employing the method
described, we have usually obtained a yield of SO to 55 per cent of serum.

Storage of Serum.-Tbe serum is stored in the refrigerator in the 6
liter bottles for at least 2 months. During this period· a fine pre
cipitate gradually sediments. It is desirable that this sedimentation
should be complete before the serum is dispensed for treatment in
order to avoid the possibility of certain reactions on the part of the
patient, due to the intravenous injection of suspended particles.
Dispensi-ng Serum.-After the requisite period of storage, the serum
is dispensed for treatment in sterile, rubber-corked bottles of 100 cc.
capacity, capped with parchment which has been soaked in 1: 20
phenol. This final bottling of the serum is accomplished by syphon
age; this time, however, the syphon action is started by raising the
air pressure in the storage flask through a co(ton-plugged tube in the
rubber stopper through which the syphon tube also passes. The
syphon tube terminates in a specially designed filling device which,
by means of a protecting bell or jacket, covers the neck of the dis
pensing bottle, thus avoiding unnecessary exposure of the serum.
All the handling of the serum is conducted in a room free from
draughts and dust. After bottling, the serum is tested for aggluti
nation and protective power and it is also subjected to a rigid test for
sterility and for primary toxicity.
Tests for Sterility. Culture Tests.-The first, middle, and last of
the dispensing bottles from each storage flask of serum are set aside
for sterility tests. From each of these bottles,0.5 cc. and 4 cc. of serum
are each mixed with about 20 cc. of 1 per cent glucos_e broth in Smith
fermentation tubes layered with paraffin; 2 fC· of serum are mixed
with about 15 cc. of melted 1 per cent glucose agar at 43°C. in deep
tubes, and, after cooling, layered with paraffin; 6 cc. of the serum are
mixed with 150 cc. of ordinary nutrient broth; all are then incubated
at 37.5 °C., and observed for 14 days. If no growth or gas produc
tion is observed in any of the cultures, the particular lot of serum is
considered sterile.
Animal Tests.-4 cc. of the serum are injected subcutaneously into
each of two guinea pigs weighing 250 to 300 gm.; the guinea pigs are
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observed for 2 weeks for evidence of toxicity or infection. 0.5 cc. of
serum is also injected into each of two mice which are observed for 4
days. This test is for the purpose of making sure that the serum
contains no living pneumococci from the last injection. However, in
these tests we have never found pneumococci present.
Use of A rttiseptics.-Employing the precautions we have mentioned,
it has been rare for any lot or sample of serum to become contami
nated. Where large amounts of serum are injected intravenously, as is
necessary in this form of treatment, the ideal method is to employ
serum to _which no preservative has been added, and under the
conditions in which we have employed the serum, we have shown that
this is practical. The serum should, of course, be kept in the dark
and in the cold. Under these conditions serum which we have kept
several years has remained uncontaminated.
If manufacturers
feel that this method on a large scale is impractical, chloroform or
tricresol may be added to the serum before bottling.
At present, most State Board of Health laboratories employ chloro
form for the preservation of serum which is to be injected intrave
nously, and this is probably preferable to tricresol or other phenol
preparations, though in the treatment of cholera large doses of immune
serum, which have contained 0.5 per cent phenol, are said to have been
employed (7) without injurious effects. Undoubtedly, however,
where large amounts of serum are to be injected, the use of a volatile
preservative, as chloroform, is preferable. The following is the
method at present employed by the Department of Health of the City
of New York: After the serum is drawn into the large flasks, an
excess of chloroform is added, about 5 cc. to 1 liter. When the serum
is drawn off for bottling, the excess of chloroform is left, together
with the sediment, at the bottom of the flask.
Preservation of Potency.-We have examined samples of serum kept
on ice and in the dark after a period of 2 years. No loss of strength
could be detected by the methods used. If allowed to stand at room
temperature and in the light, a fairly rapid, loss of potency occurs.
In the experience of Neufeld and Handel (14) also, antipneumo
coccic serum keeps many months unchanged. They also found that
neither heating to 59°C. nor the addition of carbolic acid causes any
loss in potency.
I
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Concentration of Serum.-Experimental evidence and clinical ex
perience have demonstrated that antipneumococcic serum must be
administered in large doses if success is to be obtained in this method
of therapy. Any method of concentrating the serum without de
creasing its antibacterial potency, therefore, would be of great value
in rendering its administration more convenieq.t and practical. If
concentrated serum were employed, moreover, the frequency of
serum disease would be decreased, or at least the symptoms would be

ameliorated.

Study of the distribution of the immune bodies occurring in anti
pneumococcic serum has shown that both the agglutinins and protec
tive antibodies are associated or combined with the globulins, and
not with �e albumin of the serum (R2). Hence concentration
by fractional precipitation of the globulin fraction with ammonium
sulfate is possible. This procedure; however, is attended with cer
tain disadvantages. Bacterial contamination of the serum neces
sarily occurs during the procedures attending the chemical manipu
lations. Although the bacteria may be removed by filtration through
a Berkefeld filter and their growth inhibited by the addition of pre
servatives, the products of bact"erial metabolism remain and may ex
hibit a toxic action when injected intravenously. It is doubtful,
therefore, whether serum · concentrated in this manner should be
employed for intravenous use.
Gay and Chickering (R15, R16) have shown that the mixture of a
solution of pneumococcus bodies and homologous antiserum results
in the formation of a voluminous precipitate, which contains practi
cally all the immune substances of the serum. The immune
bodies contained in this precipitate can now be extracted in a dilute
alkaline solution at 42° C. The resulting water-clear extract possesses
the power to protect animals against pneumococcus infection and it
also contains other demonstrable antibodies, such as agglutinins
and precipitins. By this meth?d a large proportion of the antibodies
can be concentrated in a volume which is only one-fifth to one
tenth that of the original serum, and in which there is only one-sixtieth
of the native protein. This biologic method of concentrating anti
pneumococcic serum, while yielding an end-product which is ideal
in many ways, is nevertheless laborious in technique, and the prep
arations obtained are of very inconstant strength and are not stable.
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While, ther.efore, concentration of antipneumococcic serum can be
effected by either chemical or biologic methods, the disadvantages
attending both of these processes are such that as yet neither has
been found of practical utility.
Standardization of Serum.

In order that any serum may be used therapeutically, it is important
that there should be some method of determining the strength or po
tency of the samples employed. Without this, no constant dosage
can be obtained, and any estimate of the effectiveness of the serum
is difficult or impossible. The method used for standardization of
antitoxic sera, such as diphtheria and tetanus antitoxin, is almost
ideal. Here it is possible to establish toxic and antitoxic units,
and the law of multiple proportions holds good for these units within
very wide limits; if 1 cc. of serum neutralizes 1,000 units of toxin,
0.001 cc. will neutralize 1 unit of toxin, or 100 cc .. will neutralize 100,000
units, almost with the constancy of chemical acid-base neutralization.
An analogous method of standardization for antipneumococcic
serum has been proposed, but there are great difficulties in the
way of using such a method for this serum. No pneumococcus toxin
has yet been demonstrated and the employment of an antitoxic unit
is therefore impossible. Nevertheless, it might be possible to make
use of the same principle of standardization, using bacteria themselves
instead of their toxin, provided that a minimal lethal dose of bac
teria could be est�blished, and provided that the reaction between
the minimal lethal doses and varying quantities of serum obeyed the
law of multiple proportions. The attempt to employ such a method
has been made by Eyre and Washbourn (3) and others. The establish
ment -of _a minimal lethal dose of pneumococci, however, is a matter
of extreme difficulty. Pneumococci vary greatly in their virulence
from time to time. With every passage through an animal or on
artificial culture medium, an alteration occurs. This change may
not appear very great, as estimated by our usual methods, but
in relation to the great accuracy required in the establishment of
a minimal lethal dose, the changes are enormous. It is only in organ
isms possessing the maximum degree of virulence that the virulence is
at all stable. However, when cultures of high virulence are inoculated
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into susceptible animals, as rabbits or mice, which are usually employed
for these tests, it is found that v.ery few bacteria, at times even a single
organism, are sufficient to cause a fatal infection. With these bacteria
the determination of the minimal lethal dose would be extre�ely
difficult, if not impossible. Our studies indicate, however, that if
such a unit could be established, the antiserum, when tested against
it, would probably be found to obey the law of multiple proportions.
Nevertheless, on account of the difficulty of accurately establishing a
minimal lethal dose, this method does not at the present time seem
practicable.
This failure to establish a unit for antipneurnococcic serum, how
ever, is not so serious as it might seem. The main practical object
to be gained by the employment of thls method of standardization
would be that the dosage might be very accurately regulated, and that
sera of weak power might be employed, provided that a sufficient
amount were used. However, experience has shown that the maxi
mum strength of any antipneumococcic serum that can be produced.
by present methods is limited. This limit is quite constant and
differs for the different types of pneumococci employed. In order to
obtain practical results in treatment, even with serum of this maxi
mum strength, very large amounts must be used. Therefore, even
if we had such a method of standardization as that above mentioned',.
it would not be practical to employ sera of low potency, nor would
it be of great ad.vantage to be able to estimate very accurately the·
exact potency of the dosage. Such a method of standardization of
antipneumococcic serum therefore i�, at the present time, neither
possible nor necessary.
In the abse�ce of an absolute standard, it might be possible to
devise a test for determining the relative value of different sera,
by making use of certain phenomena, as agglutination or opsoni
:fication. In these phenomena, if the amount of bacteria employed
is not too great, the reaction is entirely proportional to the con�
centration of the serum in the mixture, not to its actual amount.
At ]east, the only method we have at present for measuring the
power of a. serum to produce agglutination, consists in the determi
nation of the maximum dilution at which the serum acts, and this is.
practically independent of the number of bacteria acted upon. There.:..
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fore, if the effectiveness of a given serum depended upon its agglu
tinating power or were proportional to it, this property could be em
ployed to fix the strength of any serum, and in such a, method the·
great variable, the living bacteria, would be eliminated. Even in
the absence of an absolute standard, we should then have a relative
standard of efficiency. If bacteriotropic power were employed, how
ever, the bacterial varlable would not be eliminated, since it has
been shown that different bacteria vary greatly in the�r susceptibility
to the action of bacteriotropic sera, and this variation is to some
degree dependent upon virulence. In any case, however, the hope of
,devising a method of standardization, employing either' agglutination
or bacteriotropic action, has been destroyed by the observation that,
while there is frequently some gross quantitative relationship be
tween the protective action of a serum and its agglutinating or bac
teriotropic power, this relationship is inconstant. For instance, we
have had sera with high protective power and little or no agglutinating
power, and vice versa.
Although it is not p�ssible to establish an anti-infection unit and
although it is not possible to employ the properties of agglutination or
opsonifica.tion in the ways we have mentioned for estimating the rela
tive strength of sera, it is still possible _to have a sta:ndard that will
be of great practical value in the therapeutic employment of this
serum. If a minimum potency for those sera that are to b� employed
therapeutically can be established, which minimum is not far be�ow
the maximum possible, we shall have gone far in standardizing the
treatment of cases by serum, even though this method does not
make possible :fine distinctions in dosage or the use of sera of weak
strength. It is, of course, necessary that serum of �e strength de
termined upon can be produced without too great difficulty. Other
wise great waste would result and the whole method would be
.come impractical. . In view of what we have already stated in regard
to agglutination and opsonification, these properties cannot be em
ployed, but the potency of a given serum must be ascertained'by direct
,determination of the protective power of the serum for animals. In
·-Order to establish by this method such a limit of potency .as we have
�suggested above, thete must be some constant relationship between
-the size of the infection dose and t.he amount of serum nec�ssary to
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protect; in other words, the serum must obey the law of multiple
proportions.
'

Neufeld (14), who first studied this qtiestion, decided that antipneumococcic
serum, as tested by protective power, obeyed this law only within given limits
and under certain conditions. His experiments seemed to show that the results
were regular until the serum had been diminished to a certain amount, depending
on the weight of the animal employed. When an amount of serum less than this
· was employed, the relation of serum to culture no longer held constant; this
smaller amount of serum would protect only against a very much less amount of
culture t�an that calculated. From this he judged that to obtain effective action,
even against minimal doses of culture, a give}l concentration of serum in the body
(not actual amount) is required. This effective limit to the action of serum he
called the Schwellenwert. His experiments were performed on mice and he did
not mix the culture and serum before injection, but injected them separately
in different parts of the body and usually allowed a period of time to elapse be
tween the injection of the serum and that of the culture.

This matter was later studied in this hospital, but rats were· em
ployed and the given amount� of culture and serum were mixed in
the syringe immediately before injection. It was found that the law
of multiple proportions held valid as long as small amounts of
culture and serum were employed; that even extraordinarily small
amounts of serum would protect against proportionally small doses
of culture. The relative amount of serum necessary to protect against
larger doses of culture became greater and greater, however, as the
size of the doses of culture was increased, until :finally no amount of
serum, however large, was able to protect.
The explanation of Neufeld's results lies in the fact that the serum
was injected separately from the culture and, owing to the length of
time required for diffusion of small amounts, multiplication of the bac
teria had occurred and the degree of infection had increased enor
mously and the infection had become widespread before the serum
became effective at the site of injection. Our experiments suggest
that in the action of immune serum a body or tissue factor is essen
tial, in addition to the substance contained in the serum. If the infec
tion is not too great, this factor is adequate. If, however, the infection
is enormous, this factor is no longer sufficient. Within given limits,
however, any variations in this factor are not important and, more
over ' within these limits the relation of serum to culture is fairly
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constant. This fact is of great importance, as upon its va�dity
depends the possibility of establishing a standard of potency.
From these experiments and tp.ose of Neufeld, it has b�en decided
justifiable to fix a definite standard of strength to which sera used
for therapeutic purposes should conform, determining this strength
by direct estimations of the protective action of a definite fixed ·
amount of the serum for mice against variable amounts of culture of
high virulence. In such estimations as these it is obvious that while
variations in virulence are important, slight variations make no great
difference, as they would in determination of the minimal lethal dose,
provided that the virulence is near maximum. The amount of serum
to be employed in the tests also is not of great.importance, provided
that it is always the same and provided that it is selected within
the limits where the law of multiple proportions holds valid.
Theoretically, it would be better to titrate several amounts of serum
against varying amounts of culture, choosing these amounts of serum
at various levels. Practically, however, this would render the
method too complicated for ordinary use, and it has been found suffi
cient to use one amount of serum, provided that this amount is not
too great or too small, and that the same amount is used for all tests.
Neufeld (17) used 0.2 cc. of serum for this purpose and we have
found this satisfactory. Wadsworth and Kirkbride (30) have recom
mended using 0.1 cc. of serum without, however, giving any definite
reasons for the change. Since much work has already been done
using 0.2 cc., it seems best to continue this method.
We realize that the method of standardization w)rich we advise is
far from ideal. At the present time, however, it seems to be the
only practical one, and., if applied with care and attention to details,
it will at least prevent the use of sera of low potency, and, we be
lieve, will make the therapeutic use of antipneumococcic serum both
possible and effective.
Technique of Standardization Test.-In making a practical test of the
protective power of the serum, white mice weighing 18 to 22 gm. are
employed. The largest amount of an 18 hour broth culture of the
homologous pneumococcus against which a constant quantity of
the serum, 0.2 cc., will protect, is determined. Various dilutions
of the broth culture are so prepared that each 0.5 cc. of the mixtures
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contains a given quantity of the pneumococcus culture, from 0.2 cc.
to 0.0000001 cc. The dilutions are made in peptone broth similar
to that in which the bacteria are grown, and a separate pipette is
used for making each dilution in order that an accurate distribution
of the bacteria may be obtained, and to avoid ca1Tying over any
bacteria from the lower to the higher dilutions. The dilutions are
made immediately before being used so that do growth or other change
may occur in the mixtures. At the sai::ne time a small amount of
the serum is diluted in broth, two parts of serum .to three of broth,
so that 0.2 cc. of serum is contained in each 0.5 cc. of the mixture.
Whe}) injecting the animal, 0.5 cc. of the diluted serum is taken up
into a 2 cc. Luer syringe and then 0.5 cc. of the diluted culture which
is to b� injected. The mixture of serum and culture is then injected
at once intraperitoneally. The needle of the syringe is run under the
skin a little above and parallel to Poupart's ligament and then ob
liquely through the abdominal wall. By this method injury to the
liver, large blood vessels, or kidneys is avoided. In making a test
of a given amount of serum, usually injections are made of 0.2�
0.1, 0.01, 0.001, and 0.0001 cc. of culture, each mixed with 0.2 cc.
of the serum to. be tested. It is best to inject "two mice with each of
these amounts. In making the series of injections one should com
mence with the mixtures containing the smallest amount of culture.
It is then possible to use one syringe for all the injections. As a con
trol of the virulence of the organisms used, another series of mice
should be injected with these dilutions of culture, each with 0.2 cc. of
the standard serum. Any marked variations in the virulence of
the organism employed will then become evident, since by the protec
tive power of the standard serum against the culture of organism em
ployed, the virulence of the latter may be estimated. As a' further
control of the virulence of the organism, three mice are injected in
traperitoneally, one receiving 0.0000001 cc., one 0.000001 cc., and
one 0.00001 cc. of culture. The actual number of organisms contained
in the culture employed is determined· by making agar plates from
each of these dilutions of culture and estimating the number of colo
nies appearing after 24 hours' incubation. With the same proportion
of peptone in the broth and a standard acidity, it is surprising how
nearly equal the numbers of bacteria contained in 1 cc. of each of the-
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various cultures are. Usually 0.0000001 cc. of culture gives rise to 10
to 30 colonies on the plate, which means that the number of bacteria
contained in 1 cc. of the broth culture is from 100 to 300 million.
It is our plan to mark the mice by staining a given part with carmine,
and it is well to have a regular system for doing this and marking
each animal before it is released from the hand. As the mice are
injected, they are placed in glass jars containing sawdust and covered
with pieces of wire netting. Care should be taken that they are
not overcrowded (not more than three or four mice in a jar) and they
should be kept in a room with an even temperature. They should be
observed over a period of 5 days. With a virulent pneumococcus the
controls, receiving culture· alone, should die within 48 hours. These
mice, as well as those unprotected by the serum, should haye cul
tures made from the heart's blood in order to make sure that pneu
mococci are present and that some extraneous factor has not been the
cause of death.
The best Type I sera that we have been able to produce have
not protected regularly against doses higher than 0.2 to 0.5 cc. of
culture. Most of them have not protected regularly against doses
over 0.2 cc. We beJ!eve, therefore, that for therapeutic use only
those sera should be employed which in doses of 0.2 cc. protect regu
larly against at least 0.1 cc. of a culture which is shown by the ani
mal and standard serum tests to be of proper virulence. The viru
lence of the organism used in the protection test is usually such that
0.000001 cc. of an 18 hour broth culture will kill a mouse of 20 gm.
weight within 48 hours. The following protocol illustrates the exact
method of carrying out the test:
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Typical Protocol of Standardization Test.
No. of mouse.\

Marked.

Culturl!-

Scrum.

Result.

Serum, Horse XX, Lot 4.
cc.

1

2

4
5

6
7
8
9
10

Head.

"

Back..

"

Right hind leg.

" "
" "
Left
" " "
Right fore "
" " "
"

0.2
0.2
0.1
0.1
0.01
0.01
0.001
0.001
0.0001
0.0001

cc.

0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2

D.* 48 hts.
s. 5 days.
s. 5 "
s. 5 ""
s. 5

0.2
0.2
0.2
0.2
0.2
0.2

D. 4 days.
D. 48 hrs.

s.
s.
s.
s.
s.

"
"
"
5 "
5 "

5

5
5

Standard serum.
11
12
13
14
15
16

Head.
Back.
Right hind leg.
" "
Left
Right fore "
"
Left

0.5
0.4
0.3
0.2
0.1
0.01

17
18
19

Head.
Back.
Right hind leg.

0.00001
0.000001
0.0000001

"

-

-

s.
s.
s. .
s.

5 days.

5
5

5

"
"
"

D. 12 hrs.
D. 24 "
D. 36 "

* D., died; S., survived.
In our experience sera produced by the injection of Type II or
ganisms never regularly protect higher than in the ratio of 0.2 cc. of
serum to 0.01 cc. of culture. The protective power of Type III serum
is still less.

SERUM TREATMENT.

Indications Jor Serum Treatnient.
1

1t has been proposed by others that immediately after admission
to a hospital or after coming under the care of a physician and before
the type of infection is determined, every patient should receive a
large dose of antipneumococcic serum of Type I or a polyvalent
serum containing antibodies to Type I pneumococcus. The purpose
of employing this method i6 to avoid the delay incident to the de
termination of the nature of the infection. Later, if the infection
proves t<:> be due to Type I pneumococcus, the treatment may be
continued; otherwise it may be stopped. As we shall show later, the
administration of serum is frequently followed by general constitu
tional reactions and, if this method were employed, many patients
in whom the serum could be of no possible value would be subjected
to these reactions. The time gained would not be great, since, in
most cases, the type of infection can be determined within 6 to 18
hours, and during this time, if the patient is sensitive to horse serum,
he can be des�nsitized. Pneumonia is the easiest of the acute infec
tious diseases to diagnose. If the importance of early diagnosis and of
type determinations were generally recognized, serum treatment could
be commenced very early in most patients, even though the etiologic
diagnosis caused slight delay. We therefore believe that except in
emergencies the administration of serum should only follow the
determination of the nature of the infection.
As soon as the type of pneumococcus responsible for the infection
has been determined, if it proves to be Type I, serum treatment
should be undertaken at once in all cases, except in very young chil
dren who appear but little intoxicated by the infection and in whom
the prognosis is good and the difficulty of treatment great. In
the case of adults, first seen late· in the disease, apparently mildly
�11, and already showing signs of decreasing fever and intoxication,
serum treatment may also be unnecessary. When cases are seen late
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in the disease, still very ill, one should be extremely careful to elimi
nate complications as the cause of the symptoms. The value of the
intravenous use of antipneumococcic'serum in otitis media, empyema,
pelvic or joint abscesses, pneumococcus pericarditis, or meningeal in
fections h�s not been demonstrated. Occasionally one is tempted not
to use serum, or at least to wait a day or two, in cases which seem
relatively mild at onset. This is believed to be most unwise, as fre
quently the pathologic process spreads insidiously, giving little evi
dence of intoxication for several days, when suddenly the picture
changes, the pulse, temperature, and respiration rise, cyanosis deepens,
and the end comes too soon to be influenced by the tardy use of the
specific serum.
Occasionally one first sees a case at a time when consolidation of an
other lobe is taking place. At such a time the temperature may
perhaps be lower and the heart rate and respirations slightly less
previously. On the other. hand, the general appearance
rapid than
.
of the patient does not seem reassuring; he may appear prostrated,
and the extremities may be moist and clammy. In a few hours the
temperature rises again, and the following day the signs of more exten
sive consolidation may be more apparent. These cases especially need
immediate treatment when first seen if the further spread of the
disease is to be prevented.
Administration of Serum.

Antipneumococcic serum can be administered most easily in a
hospital where trained assistants and sterile materials are always
available, but it may be given anywhere, in the home or in the field,
in fact wherever water can be boiled and iodine and alcohol
obtained.
Following the administration of foreign serum, especially the large
amounts necessary in this form of therapy, the patient may exhibit
certain symptoms which are entirely due to the foreign ·protein and
have nothing to do with the content of the serum in antibodies.
This reaction is identical with, or at least analogous to the so called
anaphylactic reactions· seen in animals. It is very important that,
before serum is administered, every effort should be made to ascertain
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whether patients are highly sensitive to horse serum, in order that
such reactions may be guarded against. The detection of serum
sensitiveness is not difficult. Every patient with pneu�onia, imme
diately on admission to the hospital or after coming under-the physi�
clan's care, should receive proper tests to determine this fact, since,
if he proves to be infected with Type I pneumococcus, serum should
be administered.
The patient is first questioned for a history of previous injections
of immune sera for diphtheria, meningitis, or for tetanus infections.
He is also questioned concerning previous symptoms suggesting
asthma or hay fever, since, persons having such symptoms are likely
to be sensitive to various proteins, including those in serum. In any
event, however, an intradermal skin test is performed.
Intradermal Skin Test.-The skin, preferably over the forearm,
is carefully cleaned with soap and water and alcohol, 'taking care
not to make the skin red or inflamed. If the skin is gently patted,
instead of rubbed, with a gauze sponge, no irritation develops. With
a small syringe, preferably of the type used for tuberculin injections,
and a :fine needle, about No. 28 gauge, 0.02 cc. of 'sterile diluted horse
serum (normal or immune), diluted with salt solution 1 :10, is in
jected into the skin, not subcutaneously, so that a small white wheal
about 3 mm. in diameter showing the little depressions of the hair
follicles is produced. An injection of a like amount of sterile salt
solution is made as a control. It is advisable to make the serum and
the control injections at one level on the forearm, about 3 to 4 cm.
apart, in order that the test may not be obscured by the possible
spreading of the injected material along the lymphatics.
The points of injection should be observed at intervals for 1 hour.
Usually after a few minutes the wheal p.roduced by the salt solution
disappears, leaving no alteration in the skin except the small needle
puncture. If the test is negative, that is, if no evidence is obtained
of horse serum sensitiveness, the wheal produced by the s�rum in
jection fades away also almost a.s rapidly. On the other hand, if
sensitiveness does exist, usually within 5 minutes a genuine urticaria!
wheal begins to develop, which may increase slowly in size up to
that of a half dollar; the wheal in turn being surrounded by a larger
area of erythema. This lesion usually reaches its m�ximum extent
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within 1 hour and fades away rapidly, disappearing entirely within
a few hours. A faint erythema, may persist for a day or more.
There are usually no subjective symptoms from this intradermal injec
tion, except occasionally slight itching at the point of injection. Very
rarely, in individuals extremely sensitive to horse serum, the in
jection of this small amount of serum, 0.002 cc., has been known to
produce general symptoms, flushing of the face, increased rapidity
of the heart rate, and respiratory discomfort.
Desensitization.-It has been shown that even very susceptible
and highly sensitized animals may be completely desensitized, so
that they can tolerate large amounts of the serum to which they are
sensitive, if repeated injections are made, beginning with an ex
tremely minute dose and following this with doses of gradually
increasing size. Even administering the serum with extreme slow
ness may be sufficient to prevent anaphylactic shock, or the adminis
tration of a very small dose, several hours before the large injection,
may protect animals that are not highly sensitive. Therefore,
for purposes of desensitization, it is advi,sabl� to. inject' 0.5 to
1 cc. of a.ntipneumococcic serwn or sterile normal horse serum sub
cutaneously into every pneumonia patient as soon as the skin test is
completed, even though the intradermal skin test is negative, for
occasionally one sees a patient in whom the skin test appears to be
negative and yet in whom, on the injection of large amounts of serum,
slight symptoms of serum sensitiveness appear. It is believed that
the subcutaneous injection of a small dose of serum will desensitize
a patient for from 6 to 8 hours to several days. However, this pro
cedure should not be relied upon to the extent of giving the subse
quent intravenous dose at a rapid rate. We know of at least one
instance in which a desensitizing dose of 1 cc. of serum injected sub
cutaneously failed to prevent the development of a severe anaphy
lactic reaction in a patient who had received an intravenous dose of
.serum 10 days before. In our hands, however, the use of the pre
liminary intra.dermal and subcutaneous serum injections, we believe,
has contributed much to our freedom from untoward symptoms
during or after serum treatment.
If the intradermal skin test is positive, indicating that the patient
is sensitive to horse serum and if the infection is due to Type I pneu-
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mococcus, in which case the patient should receive serum treatment,
a more thorough method for desensitization must be employed. This
should consist in giving extremely small amounts of serum subcu
taneously at ½ hour intervals, doubling the size of the dose at each
injection. One can safely begin with the injection of 0.025 cc. of
serum. If no reaction follows the injection of 1 cc., subsequent
doses may be given intravenously, also at½ hour intervals, beginning
with 0.1 cc. and doubling the dose at each injection. If a general
reaction occurs, or cyanosis, dyspnea, or increased rapidity of the
heart rate supervenes, the injections should be suspended for 2 to 4
hours, depending upon the severity of the reaction, and then be
resumed, starting with the same dose as that producing the reaction.
After 25 cc. of serum have been given· in these small doses, after a
lapse of 4 hours, 50 cc. may be given, followed by the regular dose 6
to 8 hours later. The desensitization of a patient is a tedious and
time-consuming procedure. Fortunately one rarely is called upon
to employ this measure. It has been found necessary to desensi
tize in this way only two or three patients in a series of over 150 cases.
Technique of Treatmerit.-In preparing for the intravenous in
jection of serum it is best, though not necessary, to have a sterile
field; that is, sterile towels, gloves, etc. It is, however, quite possible
to inject ·serum aseptically with only a package of sterile gauze
sponges and iodine and alcohol to disinfect the patient's skin about
the point of injection. The apparatus for injecting the serum is shown
in Text-fig. 2 and consists of the following:
1. Sterile contai�er for mixture of antipneumococcic serum and sterile freshly
distilled normal salt solution.
2. Rubber tubing, 4 feet long, and a three-way stop-cock.
3. Short piece of glass tubing for a window.
4. Rubber stopper with double holes through which are thrust two pieces of
glass tubing. One tube is long enough to reach nearly to the bottom of the
container, and through this air enters the container when the latter is inverted.
The other shorter glass tube forms the outlet for the serum.
5. Two sharp needles a.lid needle holder.
6. One 20 cc. Luer all glass syringe.
7. One 2 cc. Luer all glass syringe with hypodermic needles.
8. Thumb forceps.
9. Medicine glass.
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Adapter for
k:syrlnge

------.Q)

TEXT-FIG. 2. Apparatus·for injection of serum.

All' this apparatus should be· assembled and sterilized by boiling
for 20 minutes in a covered dish. It is important to rinse· out
the tubing thoroughly after it has been -used; otherwise with a sub
sequent steri�zation any serum remaining in the tubing will be coagu-
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lated and plug the apparatus. This material in the tubing may also
be responsible for unexpected reactions on the part of the patient
when it is accidentally injected along with the serum. To avoid
this difficulty, the rubber tubing may be almost entirely replaced by
lengths of glass tubing short enough to be contained in the sterilizing
receptacle. These are connected by short pieces of rubber tubing 2
inches long, which are easily cleaned and can frequently be discarded
for fresh ones. The serum should be warmed before injection to
slightly above body temperature. It has been customary to dilute
the antipneumococcic serum with equal parts of sterile freshly dis
tilled (glass still) salt solution just before the injection is made.
This makes the serum less viscous and facilitates its flow through
the tubing. If salt solution properly prepared for intravenous use
cannot be obtained, the serum may be used in its undiluted condition.
The slow injection of the smaller amount of fluid during 25 to 30
minutes is, however; somewhat difficult.
When one is ready to make the injection, the serum is transferred to
the container by means of a sterile pipette. In this way the trans
ference of the small amount of sediment which is always present in
the bottom of the bottle (if care has been taken to prevent shaking)
can be avoided. If no pipette is at hand, the serum may be carefully
poured from the bottle to the container, taking care that the sediment
is not disturbed. This sediment may do no special harm, but its
administration should be avoided if possible. When no container
is available, the serum may be injected directly from the bottle, with
a syringe with a long needle. The method described1 however, is
the one of choice.
Having filled the container, the cork is inserted and prevented
from falling out by st.rips of adhesive tape. The bottle is inverted
and attached to the side of the bed or to an irrigating stand. After
allowing the serum to fill the tubing, the needle is introduced into
a convenient vein, usually at the bend of the elbow, the overlying
skin being previously cleansed with iodine and alcohol. If one has
facilities for making blood cultures, it is wise to take about 10 to 15 cc.
of blood for blood culture before beginning the serum injection. The
serum may be allowed to run into the vein very slowly by gravity,
but may be more easily and accurately controlled by aspirating it
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�to the syringe and then in turn injecting it into the vein (Fig. 5).
In this way it is possible, and indeed advisable, that the steady and
sl9w injection of the first 10 to 15 cc. of serum should occupy 10 to
15 minutes. During this period one watches carefully for any change
in the patient's appearance and for increased rapidity of the pulse,
respiratory difficulty, pallor, cyanosis,or urticaria. If these symptoms
appear, it is well to stop the injection of serum for a few minutes, 15
to 20, to see if the symptoms increase in severity. Usually they
rapidly disappear and the injection can be resumed. The needle
can be easily kept free from dots by slowly injecting salt solution with
the detached syringe. The serum can be kept at about body tem
perature when being injected slowly by placing the tubing between
two hQt water bags just before it reaches the patient.
Except in very rare instances, no symptoms arise during the in
jection of the first 10 or 15 cc. of serum, and the injection may then
be completed more rapidly in 10 to 15 minutes. As soon as the needle
is in the vein and is kept motionless, the patient experiences no dis
comfort; in fact, in most cases the patient dozes' quietly during the
treatment. With nervous individuals, the infiltration of a small
area of-the skin at the point of injection with 1 per cent cocaine or
novocaine solution renders the whole procedure painless.
Dosage and Frequency of Treatment$.

Practical experience has now shown that for antipneumococcic
serum to be effective it must be given in large doses and intrave
nously, in order that a wide distribution of immune bodies throughout
the body may occur rapidly. As previously stated, the exact mode
of action of the serum is not yet certain; nevertheless to obtain satis
factory results, it is necessary to inject sufficient serum to produce
in the patient's blood a concentration of antibodies such as that which
occurs during natural recovery from. the disease, for we believe
that it is largely upon this factor that recovery depends (15, R32).
If to obtain- this result required merely the addition of a definite
amount of the serum to the patient's blood, just as we might
make a dilution of the serum in normal blood in the test-tube, there
would be little difficulty. However, experiments have shown that (R

68

ACUTE LOBAR PNEUMONIA

30) not only do the bacteria circulating in the blood fix antibodies and
so render them ineffective, but in the infected patients the blood
contains soluble substances which fix antibodies ju.st as do _the
bacteria themselves. In the severely infected patients these soluble
substances may be present in very-large amounts, and it is only after
these substances are all saturated that an effective concentration of
immune bodies in the blood can be obtained. Moreover, it is not
only necessary that the desired concentration of antibodies should
be present immediately following the injection, but also that this con
centration should be maintained. We have shown that as soon as this
object is accomplished, unless the infection has lasted too long and
has become too great, there occurs a fall of temperature and recovery
from the disease.
The amount of serum necessary, therefore, will vary in each case.
At present we have no means of deciding in the individual case what
the primary dose should be. Neufeld, on the basis of the theory of
Schwellenwert, decided that in the average man the dose should be
about 75 cc. We also think the dpse should be large and, from our
experience and from the observations concerning· neutralizing sub
stances in the blood of infected patients, we have established more or
less arbitrarily an initial dose of our standard serum of 90 to 100 cc.
The frequency and size of the succeeding doses must be regulated
largely by the effects obtained from those preceding. It was hoped
that it might be possible to regulate the succeeding doses by determin
ing the antibody content of the patient's blood at frequent intervals.
This procedure is too complicated to be carried out regularly, even in
hospitals that are best equipped for such work. In others this method
is absolutely impossible. We must therefore be guided by the experi
ence already gained from the careful study of a series of cases. We
have concluded from these studies that it is extremely important that
once having start�d specific treatment, it should be continued until a
definite favorable result has been obtained and, in order to accomplish
this, the serum should be given every 8 hours in doses of 90 to 100 cc.
unless there are indications to the contrary. Our experience has
indicated that the total amount of serum required may be diminished
by active and persistent treatment at the start. The average total
amount of serum required in our cases treated during the past winter
has been about 250 cc.
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In a considerable number of cases, within 20 minutes to an hour
following the injection of serum there occurs an elevation of temperature, followed by a marked fal.J. This is described in the following
pages as the so called thermal reaction. If the temperature con- ·
tinues low and the patient's condition is good, no further administra
tion of serum is necijssary. These patients, however, must be very
careful1y watched. The temperature should be taken every 2 hours
and, if the temperature during the next 24 hours rises to 102° F. or
over, a second dose of serum should·at once be administered. If no
fall of temperature occurs following the first dose, or if it does not
fall to 102 ° F. within 8 hours, the second dose of serum should then be
given. It is obvfous that this rule should not be absolutely hard
and fast, for the temperature is not the only guide to the patient's
condition. However, it is better to err on the side of giving the serum
too soon than of delaying too long.
·n, following the second dose of serum, no reaction occurs, within
8 hours another similar dose should be administered, and this should
be repeated as often as necessary. The patient should be observed!
day and night and the treatments should be given at night as well as
by day whenever necessary. In the cases in which no re.action is
obtained after several doses of serum, great care must be exercised
to detect the presence of complications such as empyema or otitis
media, to which the persistence of temperature may be due and on
which the failure of the serum to act depends.
Serum Reactions.
The injection of serum may be followed by several types of reaction;
first, the true anaphylactic reaction, second, the so called thermal
reaction, and :finally, usually at a later period, the symptom complex
called serum sickness or serum disease.
Anaphylactic Reaction.-In individuals who are sensitive t.o horse
·serum, there may develop at once or within 15 or 20 minutes after
the introduction of 40 to 100 cc. of serum, a more or less sev�re
asthmatic attack with dyspnea and flushing of the face, followed by
· cyanosis, sweating, cough, and general anxiety, and an urticaria!
eruption. Method� have previously been described by which these
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reactions can be avoided. According to Walker (31), however,
- reactions may occur, though very rarely, even in patients who have
not reacted positivelyto horse serum and who have received a sub
cutaneous desensitizing dose. He has found that these individuals,
though not sensitive to horse serum by the usual test, are very sensi
tive to the proteins in horse hair and horse dandruff. In these
unusual cases small do.ses of horse serum produce no reaction, but
doses of over 40 to 50 cc. of serum seem to induce a true anaphylactic
attack. In these cases the :first dose of serum usually produces com
plete desensitization and, following a second dose, even a very large
one, no reaction of this type occurs. An anaphylactic reaction; un
less extremely severe, is usually quickly relieved by �he h ypodermic
injection of 0.6 cc. of epinephrin (1: 1,000) solution or 0.5 mg. of
atropine sulfate, or both.
It is the consensus of opinion among those who have had large
experience in the administration of serum that severe anaphylactic
reactions occur with great rarity, even when precautions have
not been taken to avoid them. If all the precautions we have men
tioned are taken, serious anaphylactic shock will probably never
occur. The administration of antipneumococcic serum should
never be neglected or omitted because of the remote possibility of
the occurrence of these reactions.
Thermal Reaction.-Another type of reaction, that which follows
the intravenous injection of various foreign proteins, the so called
thermal reaction, appears usually from 20 minutes to 1 hour after the
injection, and is characterized by chilly sensations or a general shak
ing chill, slight difficulty in breathing, and cyanosis. The temperature
rises rapidly 1-3°F. and then falls, often to normal. During this fall
there may be profuse perspiration. The patient usually rests quietly
after a reaction and the general physical appearance seems improved.
These reactions apparently have nothing to do with anaphylax:is or
previous sensitization and may occur following the first dose of serum
or following subsequent doses. · Frequently the temperature remains
normal, but in other cases after 6 to 24 hours the temperature again
becomes elevated. It is this type of reaction which sometimes occurs
· following the administration of large doses of vaccines, and in such
cases has been thought by some to have therapeutic value. We have
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never felt that this reaction in itself is of benefit to the patient and
believe that it should be avoided if. possible. In certain instances
administration of the serum too rapidly or the administxation of cold
serum may be responsible. Little treatment for this type of reaction
need be given, reassurance, the application of heat to the extremities,
and warm drinks being sufficient.
Serum Disease.-Following the administration of foreign serum,
there frequently occurs a group of symptoms which together are
called serum disease or serum sickness. The symptoms are fever,
skin rashes, most frequently urticaria or erythema, edema of the
skin, general glandular enlargement, and pains in the joints, and the
symptoms may appear individually or in combination. The typical or
most characteristic serum disease consists of all or most of the symp
toms appearing together 7 to 14 days following the administra
tion of serum, the attack lasting a few days to a week or more. The
attacks may recur one or more times at intervals of a few days to a
week or even longer. Such a typical and fairly well marked disease
is not the rule, however. In most cases the course is extremely
irregular. Certain of the symptoms, chiefly the skin rashes; may
appear very early, within a day or a few days following the administra
tion of serum. Later other symptoms may appear, singly or together.
And these symptoms may reappear or persist irregularly for a month
or more. Not all cases receiving serum show the symptoms.
Mild symptoms of the disease appear in only about half of the treated
cases, severe attacks only rarely or in not more than 10 per cent
of the cases. The severity of the symptoms is not directly propor
tional to the amount of serum received, though undoubtedly the
severe cases are more likely to occur in the patients that have re
ceived large doses of serum.
The fever in the mild cases may be very slight, hardly noticeable.
In the severe cases it may· be high, even reaching, exceptionally,
104° or 105°F. The cases with fever may cause much anxiety to the
physician, since he is frequently in doubt as to whether the serum
reaction is responsible for the fever or whether the fever is due to some
complication. During the entire period of convalescence the phy·
sician should always be on his guard and, while he should realize
that serum sickness may be accompanied by marked symptoms and
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elevation of temperature, he should remember that it is unsafe to
ascribe all unu,sual symptoms occurring during this period to serum
disease. When fever occurs, frequent Roentgenographic examinations
should be made to detect the presence of delayed resoiution or the
appearance of flu.id in the chest. The occurrence of otitis media
or localized infection should be looked for carefully. If the fever is
due to serum disease, the patient does not usually appear very ill,
as would be the case if the fever were associated with some focal
complication with pus formation. The pulse is relatively Jess rapid,
sweating is uncommon, and the appetite is good. The leukocyte
count often helps in the differential diagnosis. While the total leuko
cyte count may be moderately elevated in serum sickness, up to
15,000 to 20,000, there is usually an increase in the relative number of
lymphocytes, 30 to 40 per cent, and frequently the number of eosinophils is slightly increased, 3 to 7 per cent.
The skin rash may consist of only a few urticaria! wheals appearing
intermittently, or it may be widespread and consist of a diffuse
erythema, even scarletinifo�, or it may be more irregular, suggest
ing measles. When the urticaria is extensive, pruritus may be
very marked. This is usually the most distress�ng symptom. It
may be relieved to some extent by allowing the patient to have a
bottle of calamine lotion by the bedside which he applies to the itch
ing areas as desired. Some such formula as the following may be
used:
Carbolic acid. ... . ...... .... . .... . . .. .. . ......... . . .. ... . .. 2 cc.
Calamine........ : ........ . .. . .. . . .. . . .. . . .... . ...... . . . .. 4 gm.
Zinc oxide.... ..... . ... ... . . ...... . . . . ......... . . . . ..... . . . 8 "
Glycerol .................................................. 12 cc.
Lime-water..... .... . ... .. .. .. ........ .... ...... . .... .. ... 16 "
Water up to� ............................................. 120 "

With this lotion the patient can usually be kept fairly comfortable
during the day. At night the use of epinephrin hypoden:µ.atically,
in doses of 0.6 to 1 cc., has been found useful. Following the
injection the urticaria disappears like magic for a few minutes to
a few hours, when it again returns. If one .uses epinephrin at night,
the patient wilJ often fall asleep as soon as the urticaria disappears
and will sleep several hours before being disturbed by the itching.
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Occasionally there may be considerable edema present with the
skin rash, or it may occur independently. It is most common about
the face and neck and it may be so extensive as to close the eyes.
This usually lasts only a few hours.
During the course of serum sickness there usual1y occurs slight
enlargement of the superficial lymph glands.. Somethµes only a
few of the glands are enlarged; at other times the enlargement is
general. The spleen may also become palpable, th�ugh this is not
the rule. Occasionally the cervical glands beneath the sternomastoid
muscle may become so enlarged and tender as to suggest a pyogenic
infection, but this condition usually completely disappears in 2 or 3
days.
There is rarely nausea or vomiting. Very rarely acute abdominal
pain may be complained of. There is no localized tenderness or
rigidity, however, and this condition is usually transitory.
During the serum sickness, as von Pirquet and Schick (22) have
noted, a disturbance of kidney function may be present. Longcope
(11) found that about 10 per cent of his carefully studied cases
showed albuminuria and hyaline and granular casts in the urine.
There is little change in the coefficient of urea excretion or in the
phthalein output. The excretion of water and chlorides is, however,
profoundly affected, both being rapidly diminished with the onset of
the sickness. This change in renal function is transitory and the
return to normal is usually rapid.
Accompanying the other symptoms there may develop stiffness in
the joints. The process seems to be extra-articular. There is rarely,
if ever, any fluid in the joints, nor is the skin hot or reddened. There
may be ·a slight amount of edema about the joints. All the joints
may be attacked or only one or two. A joint- frequently affected
is the temporomandibular, and this causes considerable annoyance
to the patient. Usually the joint symptoms pass away in a few days,
but may last a week. The administration of aspirin or sodium
salicylate and sodium bicarbonate usually gives relief from the dis
comfort. 0.3 to 0.6 gm. of the salicylate with 1 gm. of sodium bi
carbonate may be given every 4 to 6 hours. Occasionally the patient
complains of a headache which may persist for several days, but
this is usually relieved by aspirin.
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As previously stated, serum sickness may be very mild or it may be
prolonged and troublesome, and the joint pains and urticaria may
cause considerable distress. As far as we know, howev�r, it is never
serious, and leaves no permanent bad effects. Von Pirquet and
Schick, whose monograph contains the best description of the disease,
report no fatal cases, and we have never seen any serious effects,
even in the worst cases. The fact that serum sickness may possibly
occur should never deter the physician from giving serum. If life
can be saved, the occasional occurrence of troublesome symptoms in
a few patients is of little· importance.
Supplementary Therapeutic Measures.
General Measures .-In addition to the specific therapy advised in

the treatment of Pneumococcus Type I infections, the general hygienic
and therapeutic management of the case must not be neglected.
It is extremely important that the patient should be nursed, rather
than nurse himself, from the onset of the infection. The prognosis
in individuals who have pursued an ambulatory course during the
first few days of the disease is distinctly worse. If transfer to a
hospital is to be made, the patient should not be allowed to dress and
walk to the ambulance, no matter how mild the infection may seem.
Where impossible to move in the horizontal position, the transfer
may be made semi-reclining in a chair. Even this exertion is often
exhausting. The patient should not be allowed to help himself
to food or drink, or to bedpans. The strict enforcement of these
precautions plays an important part in the patient's recovery.
Diet.-The diet during the acute course of the disease is relatively
unimportant. In general it should be fluid, easy to swallow and
digest. Pure.es and soft boiled eggs, in addition to liquids, may be
given if the patient desires them. In some cases whisky in small
amounts may be beneficial. Water, 3,000 cc. or more a day, should
be conscientiously given.
Treatment for Abdominal Distention.-The routine use of a daily
morning enema of soap-suds aids in preventing this complication.
Distention most frequently occurs in the severely intoxicated cases.
It can frequently be controlled by proper diet, stupes, and medi-
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cated enemata. If abdominal distention occurs, milk should be tem
porarily eliminated from the diet. Stupes may be conveniently given
by applying compresses soaked in olive oil mixed with turpentine,
1 part of turpentine to 3 parts of oil, and covering with flannels
wrung out in as hot water as the patient can tolerate, the heat being
retained by a thick pad. The hot flannels should be changed fre
quently for a period of 20 minutes. A rectal tube may be inserted
to aid in the passage of gas. This entire procedure is repeated at
20 minute intervals. To be effective, the applicatibn of stupes
must be continued for a long period. Following their application,
medicated enemata may be used. A very effective enema is one
composed of ox gall 4 cc., turpentine 8 cc., asafetida 12 cc. This
combination is diluted in 1 to 2 pints of soap-suds and is followed
in 1 hour by a soap-suds enema. Usually this is effective in relieving
the distention, at least for a short time. Some cases are temporarily
benefited by the hypodermic use of pituitrin in doses of 0.5 cc.
Di,gitalis.-The experimental work of Porter and his coworkers
(23) tends to show that the heart muscle is not vitally injured
in pneumonia and that respiration usually fails before the circulation.
Cohn (Rl 7) has found that the pneumonic heart can be influenced
by digitalis in quite the same way and by approximately the same
dosage as the normal heart. Consequently it has been our custom to
use some form of digitalis as a routine. On account of the convenience
of administration and its accurate standardization, digipuratum has
been used at the Hospital of The �ock.efeller Institute, though any
standardized form of digitalis may be used in corresponding doses.
It is extremely important that the use of digitalis should be commenced
early in the disease in all patients, in order that they may be partly
digitalized before an immediate need arises. The intravenous use of
digitalis or strophanthin is thereby avoided. The intravenous injec
tion of these drugs may give rise to very serious symptoms, especially
if the patient has previously received digitalis. Under this con
dition these drugs should never be injected into the vein. If patients
are treated early, they are given 1 gm. of digipuratum at the rate of 0.5
gm. a day by mouth. If they are not seen until late in th\ disease and
appear quite ill, 1 gm. is given on the first day. With this dosage there
is usually evidence of the he�rt muscle being digitalized in about 24
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hours. If the patient's condition does not indicate its further use,
the drug is discontinued. If, ho�ever, occasion arises for digitalis
later in the disease, it is again given at the rate of 0.5 gm: a day until
the indication is satisfied, but it is not usually continued beyond 2
gm. The beneficial effects of the use of digitalis are best seen in
cases of collapse, in which the pulse rate often rises to 150 to 180.
This rise is usually due to flutter or fibrillation of the auricles. In
these cases digitalis acts by blocking the irregular and frequent
auricular impulses, so that often the ventricular rate falls below the
initial rate and the symptoms of collapse disappear.
Optochin.-In 1911 Morgenroth and Levy (12) reported the dis
covery of optochin (ethylhydrocuprein), a derivative of quinine, which
was found to have a specific bactericidal action on pneumococci both
in vitro and in vivo. The experimental studies led to great hopes
that this drug might be found to have specific curative effects in
patients suffering from pneumonia. Ex_tensive studies have been
made on the drug in The Rockefeller Institute, both experimentally
on animals by Moore (R43, R44, R45) and in the treatment of
patients by Moore and Chesney (R12, R13). To our disappoint
ment, however, in the treatment of 75 cases we have observed no
definite beneficial effects. Because of this experience and owing to
the danger of the drug producing injury to the eyes, the routine use of
this drug in the treatment of acute lobar pneumonia cannot be
recommended.
Results of Serum Treatment.

We shall here discuss only the effects of the administration of
specific serum in the cases of lobar pneumonia due to infection with
Type I pneumococcus.
General E.ffects.-We have already discussed the so called thermal
reaction which may immediately follow t.he administration of serum.
The fall of temperature associated with this reaction· may be accom
panied by amelioration of symptoms and the whole picture may
present the features of a natural crisis. This occurs, however, in
a small number of patients only. In other patients,· following the
fall of temperature and the relief of symptoms which almost always
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accompanies it, there may occur a return of symptoms and rise of
temperature, though, if serum is again promptly administered, this
practically never reaches its previous height. In other cases there
is little immediate effect of the serum on the temperature or pulse.
· In almost all cases, however, very soon after the administration of
serum the patient's general condition improves. This is not only
subjective, but is evident from the patient's, petter mental con
dition and increased interest in his surroundings. The cyanosis
becomes less, and the pulse rate frequently falls. This phenomenon
strongly suggests that, in addition to its other effects, antipneumo
coccic serum has a detoxifying effect. The exact nature of this effect
however, can only be surmised. Beginning with this general improve
ment, unless the infection has been overwhelming, there occurs a
gradual lowering of temperature and pulse· rate, and amelioration
of the other symptoms, the patient usually returning to a normal
condition within a few days. What almost certainly happens fol
lowing the administration of the serum is that the progress of the
disease is stopped. How rapidly complete recovery may occur de
pends on numerous factors. That the progress of the qisease is
stopped if sufficient serum is given is made evident by the following'
facts, in addition to those just mentioned: First, in practically all
cases, following the administration of the serum, there has been no
extension of the local lesion. In certain cases in which the serum has
been administered early, sometimes only a very small portion of a
lobe has become consolidated. Second, invasion of the blood by
pneumococci has been prevented (page 35). Slight invasion of the
blood by bacteria probably always occurs at some time during the
disease, at least in all but the very mild cases. In the more severe
cases a true septicemia is usually present, and this always occurs
in the cases ending fatally. In our opinion the fatal outcome is
usually dependent upon this general infection. Now, in almost
every case in which we have administered serum and in which the
blood culture was positive before the administration of the serum,
one dose of serum, or at the most two, has resulted in the blood
becoming sterile. This fact seems to us of great importance .in.
judging the efficacy of the serum. Third, following the administra
tion of the serum, there• appear in the patient's blood the immune
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bodies which normally appear only at or about the time of crisis.
It is possible, of course, that these immune bodies are only those
contained in the serum administered. Whether the paiient himself
is stimulated or permitted to produce immune bodies more rapidly
or in greater numbers than would otherwise be the case is not known.
We have previously stated (page 33) that the presence of precipitable
substance in the urine is a bad prognostic sign. In several cases
where the reaction was positive at the time the administration of
serum was commenced, following the administration of serum the
reaction became negative.
Effect on Resolution and the Development of Complications.-The
administration of serum apparently causes no change in the rate of
resolution of the lung tissue already involved. This process is
apparently independent of immunity reactions, and consolidation
of the lung may persist even after the temperature is normal and the
patient is, from a superficial examination, well. There is no evidence,
however, that the occurrence of resolution is delayed or interfered
with by the administration of serum. Complications, such as
empyema, may occur even after the employment of serum. In
certain cases the complications have already been present when
the administration of serum has been commenced; in others the
complication has undoubtedly appeared after this time. From a
theoretic standpoint and from what we have learned from animal
experiments, we might expect that the frequency of focal infections
would be increased when serum treatment is employed. Infections ,
in susceptible animals are most likely to be focal when infection has
occurred after the animals have been partially immunized, either
actively or passively. Therefore if patients with severe infections
which would otherwise be fatal are insufficiently treated with serum,
it might be expected that, though the general infection is overcome
and life is saved, focal infections might occur. Our statistics, how
ever, do not show any increased frequency of complications among the
treated cases. The non-specific treatment of cases with complications
is exactly the same as though no serum had been given. Our empy
ema cases have all been operated upon and all except one have
recovered.
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Effect on Mortality.-The :final test of the effectiveness of immune·
serum must rest on the evidence concerning the saving of lives.
Although the number of cases so' far treated in the Hospital of The
Rockefeller Institute is not large, the results obtained have been so
striking that, taken in connection with the other evidence presented ,.
· and supported, as they are, by the observations of others, they indi-
cate almost certainly that the serum as employed by us has a marked
curative effect in the treatment of pneumonia of Type I. Up to the
present time 107 cases of lobar pneumonia ·of this type have been
treated with serum, and of these but 8 have died, 7 .5 per cent. When
this is contrasted with the mortality of 25 to 30 per cent, as observed.
in our cases before we commenced serum treatment and in the cases
observed elsewhere, the results obtained are definite and striking ..
During the past 5 years we have trea'ted with serum every Type I
case coming under our observation unless the case has been very mild
or unless the patient was admitted at a time when recovery had
obviously commenced. That the more severe cases were treated!.
with serum is shown by the fact that among 105 treated cases, the
blood cultures were positive before treatment was commenced in 40 ,.
or 38 per cent, while of 34 cases admitted during the same period and
in which no serum treatment was given, only 2 showed positive
blo�d cultures, or less than 6 per cent .
. In the fatal cases we have included e'very patient that received
serum, even a single dose. A brief statement as to these 'fatal cases
may be of interest. Three of the cases were treated only a few hours
before death, when they were desperately ill. One of the patients
recovered from the pneumonia, but died on the 16th day following a
pulmonary embolism. One patient was treated late in the disease
and later suffered from numerous complications, empyema, abscesses
etc., and :finally died on the 54th day from a general streptococcus.
infection. One patient had an extensive tuberculous involvement of
both lungs, with a very small area of fibrinous pneumonia in a part
of one lobe. The blood culture became negative and he apparently
recovered from the pneumococcus infection, and death was probably
due to the tuberculous disease. This leaves but two cases in which
the serum could possibly have been of use or in which any form of
specific treatment could probably have saved the lives. One of
1

1
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these cases was among the first ones treated by us and from our
present knowledge was probably treated insufficiently. He was
treated on the 5th and 6th days, dying on the latter day. The other
case was one showing an extremely high grade of blood infection,
300 colonies per cc., when he was admitted on the 6th day. In spite
of this, with very vigorous serum treatment, he lived until the 12th
day, but finally succumbed..
The results obtained by others in small series of cases in hospitals
in New York, Boston, and Pittsburgh, where the treatment could
be carried out with proper attention to details, have also been defi
nite and satisfactory. Last fall on the Mexican Border Major
Nichols (18) treated 63 cases occurring among the soldiers. Of these
63 cases, 5 died, a mortality of 8 per cent. Among 18 cases with
Type I infection not treated with serum, 7 died, a mortality of 39
per cent. From his experience 'Major Nichols concluded that "no
patient with Type I infection who dies without the early intravenous
administration of large doses of Type I serum can be said to have
received the best treatment."
Cases Illustrating the Method of Treatment with Immune Serum.
The following abstracts of cases and tempe�ature reactions illus
trate some of the statements that have been made regarding treat
ment and serum reactions.
Case 1.-R. R., age 22 years, student (Text-fig. 3). This patient was admitted
January 8 at 7. p.m., suffering from pneumonia involving the left lower lobe.
The onset had been quite typical, with chill 48 hours before admission. He was
moderatelysick, temperature 102.5°F.,pulse 115, respirations30,leukocytes31,000.
Shortly after admission 0.5 cc. of horse serum was injected subcutaneously, but
no previous intradermal test for serum sensitiveness had been made. The sputum
was bloody; a small amount was at once injected into a mouse. The following
morning tests made ·of the growth in the peritoneal cavity of the mouse showed
that the patient was suffering from an infection with Type I pneumococcus. The
blood culture taken on admission was positive, the plate showing 1 colony per
cc. At 12.17 the intravenous injection of antipneumococcic serum was com
menced. Although the serum was given slowly, after he had received about
35 cc. of serum he had some signs of serum intoxication, suffusion of face, some
r�iratory difficulty, and he vomited several times. The administration of
serum was therefore discontinued. He complained of tightness in the chest
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and a feeling of general weakness. 1 cc. of a 1: 1,000 solution of epinephrin was
injected intravenously· and the patient's condition soon returned to normal,
except that he sweated profusely. He was somewhat alarmed at what had
taken place. His condition did not materially change during the afternoon, and
at 5 p.m. serum was again administered, this time 80 cc., without any untoward
symptoms. During the evening no definite change occurred in his condition.
His temperature, however, had risen to 105.2°F. at 8 p.m., pulse 140, respirations
40. Theref�re at 12 midnight anothe;r injection of 90 cc. of serum was made.
Following this injection the temperature rose to 196.2°, pulse 150, respirations
40. He had a shaking chill during which he became cyanosed. The tempera
ture fell rapidly during the night and at 8 a.m. it was only 98.2°, pulse 108,
respirations 26. His color was good but he seemed rather weak and exhausted.
During the day his condition was excellent, but the temperature gradually rose,
reaching 101.8° at 8 p.m. He was then given another dose of serum, 100 cc.
There was no reaction of any kind following this injection. The temperature the
following morning was 99.4° and he felt quite well. There was no extension of
the process in the lungs and following this the patient made a good recovery.
During convalescence, however, he had quite severe serum sickness, the symptoms'
beginning 6 days following the last injection and sonie persisting for 2 weeks.
There occurred persistent urticaria, stiffness and pain in the joints, edema of the
face, and albumin and casts in the urine. He had some fever from January 20
to January 30, the temperature reaching 103° on January 23. However, he made
a good recovery and was discharged on February 7 perfectly well, without a
trace of albumin in the urine.

This patient illustrates well certain of the untoward effects of the
administration of serum. It is probable that if an intradermal skin
test had been made on admission, the presence of sensitiveness to
serum would have been detected. As it was, he was incompletely
desensitized, and he had a mild anaphylactic reaction. This, how
_ever, was not serious, and that he was completely desensitized
following it is shown by the absence of reaction after the subseq\lent
dose. Following.the second large dose of serum there occurred what
we have termed a thermal reaction. This was unusually severe, but
very characteristic. It is possible that the following dose of serum
might have been omitted or at least somewhat delayed, but it is
better to have erred by giving it too soon than by delaying too long.
The serum sickness was severe, one of the most severe cases we have
seen. Repeated and frequent tests of the agglutinating power of
the patient's. serum were made in this case and, following the :first
dose of the horse serum, the patient's serum acquired agglutinating
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power which increased following the second dose, and this increase
persisted. If we had observed only this case, conclusions as to the
benefit of the serum would _be difficult. Judging from the fact that ·
the blood culture was positive before the serum w�s given and,that
the patient was well, as far as the pneumonia was concerned, on the
6th day, it seems probable that the disease was shortened. In any
case he recovered, and while the symptoms due to the serum were
somewhat distressing, they were justified, when the results in the
whole series of cases are considered.
Case 2.-I. S., age 32 years (Text-fig. 4). This patient was admitted about
8 hours following the initial chill. There were defini.te signs of involvement of
both lower lobes and he presented all the characteristic features of acute lobar
pneumonia. His temperature on admission was 103.6°F., pulse 120, respirations
48, leukocytes 35,000. He appeared seriously sick; the blood culture taken on
admission was positive. Immediately after admission a specimen of sputum was
injected into a mouse, and the diagnosis of the type of infecting organism, Type
I, was determined within 12 hours. He was then given his first treatment.
The temperature at this time was 105.2° , pulse 128, respirations 44. There was
no immediate reaction following this treatment, but the next morning · the
temperature was lower, 103.2° , and his general condition was improved. Owing
to the obviously serious nature of the infection, the treatment was continued very
. actively, 100 cc. being given at 9 a.m. and 100 cc. at 4.30 p.m. No marked
reaction followed either of these injections, though after the injection in the
evening the temperature rose slightly, but fell during the night and was 101°F. at
8 a.m. At this time he was very bright; the signs of intoxication had all dis
appeared. No increase of lung involvement had occurred. In spite of this he
was watched carefully during the day and, as his temperature was rising, he
was given another dose of serum. Following this his temperature fell. His
blood was tested frequently for agglutinatiug power. This, which was negative
before the first dose of serum, reached a high level immediately following, and
this level increased with subsequent doses. He also had severe serum sick
ness, beginning very early, 3 days following the last dose of serum, and last
ing for a week, with all the symptoms, including joint pains. On the 4th
day of the serum sickness the temperature reached 103.8°. He made a good
recovery and was discharged on the 24th day of the disease.
_

This case well illustrates the importance of early diagnosis and
treatment. In this case we feel that the treatment was carried out
in a perfectly satisfactory manner and, except for the serum sickness,
the results were all that could be hoped for. The administration of the
fourth dose on the 3rd day, we think, was of great importance in
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PREVENTION OF PNEUMONIA.
Epidemiology.

Lobar pneumonia is generally considered to be an endemic and
sporadic disease. It is habitually present among the population of
certain parts of the world, showing, however, certain seasonal varia
tions in morbidity. In spite of the fact that its incidence may reach
at times a very high rate, the relation, in origin, of one case to
another has never been very apparent. Diseases of typical epidemic
,c;haracter, on the other hand; usually spring from a limited source,
attain widespread proportions often through traceable . channels,
.and, then, after a limited time, subside, perhaps not to recur again
for a period of years. Such differences between endemic and epidemic
diseases, however, probably depend more upon the facility of infec
tion and the susceptibility of the soil on which the disease is implanted
than upon any essential difference in the mechanism of communi
cation. From a public health standpoint, therefore, it is just as
important to attempt to understand and control the channels of
communication of an endemic as of an epidemic disease.
Lobar pneumonia was recognized as a distinct clinical entity in the
time of Hippocrates. In the 16th and 17th centuries widespread epi. demics are reported to have occurred, in which the character of the
disease seems to have been somewhat different from that observed
in modern times. In the 19th century pneumonia assumed a defi
nitely endemic character. At present it is a common infection
throughout the United States and Canada. It is frequent all over
temperate Europe, and in the inhabited portions of the south temper
.ate zone such as Australia, parts of South America, and South Africa.
Although it is much less frequent in the tropics, it is often seen there
.among the inhabitants of the plateau regions. Small epidemics in
limited communities such as military camps, schools, prisons, and on
shipboard are not of infrequent occurrence, probably due to the inti
mate contact among individuals which such a life entails. In recent
86
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years two epidemics of more widespread proportions have developed.
One occurred during the course of construction of the Panama Canal,
in which the disease affected principally the colored laborers brought
to the Isthmus from the West Indies. The other took place in the
Rand Mining District in South Africa. Here, as in Panama, the in
cidence of the disease was by far the greatest among the black boys
who were imported from Central Africa to labor in the mines.
These two epidemics were probably dependent upon the same fac
tors, the great susceptibility to pneumonia of individuals coming
from.regions where acute respiratory infections were uncommon and
the intimate contact dependent upon livipg in common quarters' such
as barracks and compounds.
The census of 1900 showed that in the United States somewhat over
10 per cent of all deaths were'due to some variety of pneumonia; this,
of course, includes both bronchial and lobar pneumonia, the latter
being responsible for by far the greater number. Some statistics
seem to indicate that the incidence of pneu�onia: is increasing. It
is probable that this apparent increase may be due to better
methods of diagnosis and recording. One may safely say, however,
that the incidence of pneumonia has shown no tendency to diminish.
This may be due in part to the general acceptance of the non-con
tagious character of lobar pneumonia and the consequent lack of ade
quate measures of prevention. During the same period of time
such diseases as diphtheria and tuberculosis have shown a definite
decrease in morbidity, and one feels inclined to ascribe this shrink
age to the widespread activity directed toward the limitation of these.
diseases. It is certain that until the causative factors that operate
in the continued widespread incidence of lobar pneumonia have been
brought to light, and until such facts as have been discovered receive
practical application by Boards of Health, the continued yearly fre
quency and high mortality of lobar pneumonia will not be checked.
Pasteur once said t:ka.t it is possible to eradicate all diseases of bac
terial origin, but that first one must know the bacterial agent and
record the means by which it establishes itself in the human body.
In the case of pneumonia, the greatest difficulty that stands in the
way of obtaining this knowledge is the paradoxical fact that a large ·
proportion of normal individuals may constantly harbor in their
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mouth secretions organisms which are apparently identical with those
causing the disease. This situation, however, is ,not characteristic
of pneumonia alone, for somewhat similar conditions .;i.re found in
other diseases. For instance, the colon bacillus, an organism not
far removed from the typhoid bacillus, normally inhabits the intes
tines of all healthy human beings, and certain cocci resembling the
meningococcus, the cause of cerebrospinal meningitis, are found in the
mouth secretions of healthy individuals. In these instances it has
been an easy matter to separate the disease-producing bacteria from
the more or less harmless saprophytes of normal mucous membranes
by simple bacteriological methods such as cultural and fermentative
reactions. The problem in pneumonia, however, has been a much
more difficult one, since by cultural methods it is impossible to dif
ferentiate between the more harmless pneumococci and the definitely
pathogenic ones. However, by the employment of the more specific
immunity reactions, indications of differences between these two
general groups of pneumococci have been obtained.
In view of the fact that a majority of healthy individuals harbor in
the mouth an organism which has been, until the present time, indis
tinguishable from the. pneumococcus causing pneumonia, the pre
sumption has been fairly general that most pneumonic infections are
to be considered autoinfections and that the important factor in de
termining the incidence of the disease is variation in susceptibility
brought about by exposure or other accidental occurrences. If this
assumption is true, no useful results can be hoped for from the
usual preventive measures employed in other diseases which are
designed to limit the spread of the infectious agent. At the Hos
pital of The Rockefeller Institute (R3, R51, R52) during the past
few years an attempt has been made to find out whether in reality
the development of the majority of cases of lobar pneumonia depends
upon infection with the pneumococcus which the individual habitually
carries in his mouth secretions, the immediate .onset being caused by
some factor which temporarily lowers resistance, or whether contact
infection, either direct or indirect, plays a part of some importance.
In order to throw light upon this question, the problem has been
approached from several different points of attack. In view of our
ability to recognize, by means of specific reactions, definite types of
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disease-producing pneumococci, it has been deemed important, in
addition to confirming the constancy of these types, to study also
the character of the pneumoco'cci present in the normal human
mouth. In addition to the study of the differences between the
pneumococci occurring during disease and those in the normal mouth'
the character of the pathogenic types has been followed during the .
disease and convalescence, the time of disappearance from the mouth
secretions of the pneumococci causing the disease noted, and
the type of pneumococcus by which they were supplanted studied.
The mouth secretions of a large number of healthy individuals in
contact with cases of lobar pneumonia of known type have also been
studied, in order to determine whether in the mouths of such indi
viduals 'the disease-producing types of pneumococcus occur with
greater frequency than in normal mouths and, if so, whether this
may be attributed to the intimate association, the purpose being to
detect the existence of actual healthy carriers of pathogenic types
of pneumococcus. The type of pneumococcus present in the mouth
secretions of a large number of healthy individuals in whom no his
tory of contact with lobar pneumonia could be obtained, has also
been carefully studied. The pneumococcus of the mouth has been
isolated by injecting a white mouse intraperitoneally with about 0.5
cc. of saliva, which is a sufficient quantity to kill the animal if pneumo
coccus is present. The organism has subsequently been isolated in
pure culture from the heart's blood of the mouse and the type deter
mined by means of the agglutination test.
Types of Pneumococcus in the Mouths of Normal Persons.-In Table
IX the results of a: study of 297 normal individuals are given, showing
the percentage of healthy people who habitually carry pneumococcus
in their mouths, and also a classification of the type of pneumococcus
found. For purposes of comparison the percentage incidence of the
different types of pneumococcus _in 454 cases of lobar pneumonia is
also given (Table X).
In Table IX is presented the study of the mouth secretions of 297 individuals
in whom no history of contact with an acute or recent case of lobar pneumonia
could be obtained. From the mouth secretions of 116 of these individuals pneu
mococci were isolated, whereas from the mouth secretions of 181 no pneumococcus
was obtained. Of the 116 individuals carrying pncumococcus in the mouth at
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TABLE IX.

Distribution of Dijferent Typ�s of Pneumococcus in the Mouths of Normal Persons.
Incidence.

Type of pneumococcus.

.I. ....................... .
II ....................... .
Ila ..................... .
llb ..................... .
IIx ..................... .
III ......................
IV.......................

1
0
1
7
14
34
64

Pneumococcus present .....
"
absent ......

116
181

per cent
0.8
0.0
0.8
5.8
11.6
28.1
52.9

297
TABLE X.

Incidenr:e of Types of Pneumococcus in Lobar Pneumonia.
Type of pneumococcus.

I
II
Ila
Ilb
llx
III
IV

Incidence.

151
133
6
4
9
59

92

per cent
33.3
29.3

1..3
0,9

2.0
13.0
20.3

the time of observation, the different biologic types of pneumococcus were found
in the following percentage of instances: Type I was found once, an incidence
of 0.8 pelf cent; Type II was found not at all; the Subtypes Ila, IIb, and Ilx
were found 22 times, a percentage incidence of 18.2. Of these Subtype II organ
isms, Type !Ia is the least common and Type IIx the most frequent. This
· distribution of the variants of Type II parallels the distribution of the larger,
more inclusive pneumococcus types in the normal mouth. Type III, or Pneu
mococcus mucosus, was found 34 times, a percentage incidence of 28.1. The
immunologic studies of Type III have shown that this organism is one that shows
little or no variatiori in specificity and in this it corresponds to the typical
pneumococci of Type I and Type II. On the other hand, it presents a paradox
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in that it is frequently found over long periods of time in the mouths of healthy
individuals and, in spite of this frequency, it is the cause of the smallest number of
acute cases of lobar pneumonia of the four major types of pneumococci. Type IV
was encountered in normal saliva 64 times, a percentage incidence of 52.9.
This type of pneumococcus is therefore the dominant type in the mouth secretions
of normal individuals.
Consideration of Table X shows that in a series of ,454 cases of lobar pneu
monia, Pneumococcus Types I and II was present in 284 instances, a percentage
incidence of 62.6. The dominance of these two types of organisms in disease
shows a striking contrast to their almost complete absence in the mouth secretions
of normal individuals. The · Subtypes !Ia, Ilb, and Ilx were responsible for
19 instances of disease, 4.2 per cent. Type III pneurnococcus, despite its
frequent occurrence in the normal mouth, was responsible for but 59 instances of
disease, 13.0 per cent. Type IV pneurnococcus, the commonest pneumococcus
present in the bacterial :flora of the normal mouth, was responsible for 92 of the
cases of lobar pneumonia studied, or 20.3 per cent.

Comparison of these two tables shows that the pneumococci
most commonly found in the mouth secretions of normal individuals
give rise to a minority of the cases of lob,ar pneumonia. The dis
ease produced by these organisms, with the exception of Type III,
is less severe in character, indicating a lower grade of pathogenicity
of these types for man. On the other hand, Types I and II ca.use a
majority of cases of lobar pneumonia, are of high virulence for human
beings, and are seldom or never found in the mouth secretions of nor
mal individuals who have not been in intimate association with cases
of lobar pneumonia. This seems to indicate that lobar pneumonia
due to Types I and II does not arise from infection with a pneumo
coccus which is habitually carried in the mouth, but that infection
with these organisms occurs from without.
Types of Pneumococcus in Sputum of Pneu,monia Patients.-1£ all
cases of lobar pneumonia were due to infection of the individual
with a type of pneumococcus which was more or less constantly
present in his mouth secretions, one would expect this organism to
persist or at least reappear in the sputum after recovery from the dis. ease had occurred. Therefore, a study has been made· of types of
pneumococcus present in the mouth during the disease, as well as those
present during convalescence. After the type of organism respon
sible for the disease has disappeared, the type of pneumococcus present
later has been determined.
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In Table XI are presented the results of a study in 15 cases.
These 15 cases are representative and form but a small part of the
total number of cases studied.
TABLE XI.
Persistence during Convalescence of the Type of Pneumococcus Causing_ the Disease.
CaaeNo.

Da.y of disease on which
Type of pneumococcus observation was made,
during height of disease.
reckoned from
day of initial chill .

I

. 2,456

"

2,467
2,527

I
I

2,550

I

2,571

I

2,477

II

2,536

II

Type of pneumococcus during
convalescence.

14
27
31
10
24

No pneumococcus.

"

"

I
No pneumococcus.
Ila
Ila
No pneumococcus.
IV
IV
II
Ub
Ilb
Ilb and IV
II
No pneumococcus.

25

32
9
16
23
6
13
21
29
10

17
2,543
2,586

II

2,611

II

"
"
"

25

II

11

18
31
8
22
2
1,

"

16
23

2,465

III

34

40

"
"
"

IV
No pneumococcus.

9

30
37
11
13
20
27

"
"

"

II
IV
IV
IV
No pneumococcus.
IV
III
III
Ux:
IV
Ilx: and IV
Ilx: " IV
\

.
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TABLE XI-Concluded.

.

Case No.

Tzye of pneumococ�us
during height of disease.

2,488

III

2,,550

III

2,689

III

2,640

III

Dl\y of dise1i.se on which
observation was made,
reckoned from
day of initial chill.

Type of pneumococcus during
convl\lescence

4
14
21
28
14
21

III

7

14
21
28
35

7

14
21
28

IV
IV
IV
III
IV
III
III
III
III
III

No pneumococcus.

"
"
"

"
"
"

A study of Table XI reveals the fact that only in exceptional instances
does one find in the sputum for a considerable length of time after
recovery the same type of pneumococcus. with which the individual
was infected during the disease. The exact time at which the dis
ease organisms disappear varies. They have disappeared as early
as 7 days from the date of onset of the disease, but have been present
as late as 90 days after recovery. Usually they have disappeared in
3 to 4 weeks. In a number of instances in which the disease organ
ism has persisted for an unduly long period of time, delayed resolu
tion or some chronic respiratory condition has been present. After
the disease organism disappears, either no pneumococcus is present
or the disease type has been supplant�d by one of the types which
are usually found in the saliva of normal individuals. These ob
servations indicate that the type of pneumococcus responsible for
lobar pneumonia in any individual is but a temporary and accidental
inhabitant of his respiratory passages, and, therefore, give addi
tional evidence that infection occurs from without. They also indi
cate the length of time that convalescents may be a source of infec
tion to others in case the mode of infection is by contact.
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It is seen from Table XI that Type III pneumococcus, which is
known to occur frequently in the normal mouth, disappears in the
majority of instances from the mouth flora of cases of pneumonia as
rapidly as do pneumococci of Types I and II, which induce disease
more frequently. This suggests that Type III pneumonia may also
be communicable but that, owing to the frequent occurrence of this
organism in the normal mouth, th� lines of communication may be
impossible to trace.
Pneumococcus Carriers.-Infectious diseases, aside from those
spread by insects, usually spread by immediate contact, either with a
person suffering from the disease, or with a convalescent, or with a
healthy carrier. The importance of these modes of transmission
varies. with the different diseases and in many instances more than
one of these mechanisms may be involved. Infection in lobar pneu
monia by immediate contact with a person ill of the disease undoubt
edly occurs, and we have seen a number of instances in which this
mode of infection was apparent]y responsible. With most diseases,
however, the healthy carrier may be a greater menace to the com
munity than the infected individual, largely because of failure to
recognize the carrier condition. In the epidemiology of certain dis
eases, notably typhoid and· epidemic cerebrospinal meningitis, the
importance of the carrier state is well recognized. In Table XII
evide11ce is presented to show that a considerable percentage of per
sons intimately associated with patients suffering from lobar pneu
monia harbor in their mouths pneumococci of the same type as those
causing the disease. The persons who have been studied have been
relatives · or friends, especially those who have taken care of the
patients. We have already shown that pneumococci of Types I and
TABLE XII.

Incidence of Carrier Condition in Healthy Individuals in Contact with Cases of
Lobar Pneumonia.
Type of pneumococcus
In patient.

I

II

Total no. of contacts
examined.

160
149

No. of positive contacts.

21
18

� ,em
13.1
12.1

95

AVERY, CHICKER.ING, COLE, AN:p DOCHEZ

II are not found in the mouths of normal individuals not associated
with cases of pneumonia.
For purposes of comparison with Table XII, the incidence ofi
Types I and II in the mouth flora of normal individuals unassociated
with cases of lobar pneumonia is given (Table XIII).
TABLE

xm.

Incidence of Pneumococcus Types I and II in Saliva of 297 Healthy Itulitiduals
Not in Contact with Cases of Lobar Pneumo�ia.
Type of poeumococcus.

I
II

Incidence.
�er cenl

1
0

0.33
0.00

A study of Table XII shows that of 160 healthy individuals in
contact with cases of lobar pneumonia of Type I, 21, or 13 per
cent, carried in their mouth secretions at the time of examination a
pneumococcus of the same type. Of 149 individuals in contact with
cases of Type II pneumonia, .18, or 12 per cent, were found to carry
Pneumococcus Type II. When these figures are compared with those
from 297 healthy individuals not in contact with lobar pneumonia,
in whom the incidence of Type I pneumococcus was 0.3 per cent and
that of Type II was 0.00 per cent, very little doubt can be enter-.
tained that through contact with cases of lobar pneumonia due to
Type I or Type II pneumococcus, healthy carriers arise with con
siderable frequency. In almos·t every instance in which a carrier
of a Type I ·or Type II pneumococcus has been observed, the type
of organism in the carrier has corresponded with that of the case
with which he has been associated. Carriers of Type I and Type II
pneumococcus harbor these organisms in their mouth secretions for
variable periods of time, the average being from 3 to 4 weeks. At the
end of this time the disease-producing type usually disapp'ears and
is replaced, if pneumococci are present at all, by one of the types of
pneumococcus found in the saliva of individuals who have not been
in contact with cases of pneumonia.
Types of Pneumococcus in Dust.-The possible occurrence of pneu
mococcus in dust has been known for some time. Little signifi.-
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,cance, however, has been attached to this fact: In order to determine
whether pneumococcus could be recovered with any regularity from
-dust, and what types are present, Stillman (R52) has carried out the
following study. Specimens of dust were collected as follows: A
piece of paper was wrapped about a small scrubbing brush, this in
tum was covered with a piece of cloth, and the whole sterilized in the
autoclave. The dust of the room to be studied was swept up with
the sterile brush from an area about a foot square. The specimen,
folded in the sterile paper, was taken to the laboratory where it was
mixed with 1 to 1.5 cc. of broth, and �he mixture injected into
the peritoneal cavity of a white mouse. If the animal died cultures
were made from the heart's blood and the type of organism respon
sible for its death was detennined. In all, 62 specimens of dust from
rooms .in which no case of pneumonia was present were examined.
Pneumococci were recovered from 18 of these specimens, or 29 per
cent, and were absent in 44, or 71 per cent. The frequency of oc
-currence of the different types· of pneumococcus is shown in Table
XIV.
TABLE XIV.

Types of Pneumococcus Recovered from Dust of Rooms in Which Lobar Pneumonia
Had Not Occurred.
Type of pneumococcas.

I
TI

Ila

IIb
!Ix
III
IV

Incidence,

1
0
0
4
3
2
8

per ttnJ

5:5

0
0

22
16.6
11
44.4

From Table XIV it is seen that the types of pneumococcus usually
recovered from the rooms in which healthy individuals are living
correspond, as one would expect, to those found in the mouth secre
tions of these individuals. On the other hand, the strictly disease
p�oducing types of pneumococcus, Types I and II, are not found
u:p.less possibly a healthy carrier is present� as was the case in the
one instance given in the table.
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A similar study was made of the dust of rooms in which cases of
Type I or Type II pneumonia, had occurred. In all, 183 specimens
of dust were examined. In 109 of these . pneumococcus was not
found. In 74 of the specimens of dust pneumococcus was present;
Table XV gives the distribution of the various types recovered.
TABLE XV,

Types of.Pneumococcus Recovered from Dust of Rooms in Which Cases of Lobar
Pne-umonia Due to Type I or Type II Pneumococcus Had Occurred.
Incidence.

Type of pneumococcus.

per cefll

I
II
Ila
Ilb
Ilx
III
IV

25
23
0
2
2
2
20

33.8
31.1
0

2.7
2.7
2.7
27.0

This study shows that pneumococcus is more frequently present
in the dust of rooms in which lobar pneumonia has occurred than in
those in which no pneumonia has existed,and under the former circum
stances pneumococci of Types I and II are frequently found. More
over, in these instances the type of pneumococcus found in the dust
corresponded with the type of pneumococcus causing the disease.
Conclusions Regarding Epidemiology.-When all these observations
are taken together, we have considerable evidence, contrary to the
opinion pre�ously held, that pneumonia, in a considerable propor
tion of the cases at least, arises by infection from without. This evi
dence relates mainly to the cases due to infection with Type I or
Type II pneumococcus, which organisms, however, are responsible for
over 60 per cent of the cases. Pneumococci of these types persist for
a limited time only in the mouths of patients who have suffered from
the disease, and are very rarely, if ever, present in the mouths of
normal persons who have not been in immediate contact with such
patients. Pneumococci are not infrequently found in dust, but those
of Type I and Type II are practically never found except in the en
vironment of persons sick of the disease or in the environment of
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carriers. Possible sources of infection of those who acquire infection
with pneumococci of these types, therefore, are other patients suffer
ing from pneumonia due to the same type of pneumococci, persons
who carry these organisms during convalescence, persons who have
acquired the organisms by close contact with patients (healthy
carriers), and dust from the immediate environment of patients or
carriers.
We therefore now have evidence in regard to the mode of infe'ction
in pneumonia of these two types which affords a justifiable basis for
instituting preventive measures. The conditions in regard to the
other types of pneumonia are not yet sufficiently well known to justify
discussion here.
General Preventive Measures.

If lobar pneumonia in a large percentage of instances is readily
communicable from one individual to another, as the evidence given
above seems to indicate, it is clea� that public health authorities
should take cognizance of this fact in their efforts to limit the wide
spread incidence and high mortality of this disease. Even if accu
rate knowledge of the exact mode of transmission were unknown, the
enforcement of such precautions as are taken in the effort to control
the spread of tuberculosis, epidemic cerebrospinal meningitis, and
diphtheria. would be justifiable. Since we have definite knowledge
concerning the mode of transmission in a large percentage of the
severe cases of lobar pneumonia, it is extremely important that these
, precautionary steps should be taken.
One of the essential measures for the success of a campaign against
any communicable disease is to provide the public with all the avail
able knowledge concerning it and to explain the dangers that each
infected individual presents to those with whom he comes in con
tact. The first step, therefore, in the control of lobar pneumonia
would seem to be the institution of an educational campaign·, so that
the public mind may be receptive to such measures of control as
may be deemed necessary.
In order that public health boards may institute the measures
nec�ssary for the control of an epidemic disease, it has been found
essential that they should obtain knowledge of the incidence of the
'
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disease in a locality, and of the focal. distribution of the cases.
The only means by which this knowledge can be acquired is through
compulsory notification. Certain Boards of Health now have regula
tions requiring notification of cases of lobar pneumonia, but these are
rarely enforced, and at present the incidence of this disease can only
.. be approximately determined by calculation from the mortality sta
tistics. Such a measure would not, in all probability, meet with
public opposition, as has developed from the attempt to bring
about compulsory notification of tuberculosis or venereal disease.
Because of the ease and rapidity with which· the diagnosis of lobar
pneumonia is made by the practitioner, the statistics obtained would
probably be quite accurate. In view of the fact that only certain
types of lobar pneumonia have been shown to be communicable,
public health laboratories should be equipped to determine the type
of pneumococcus responsible for each particular case of the disease.
Additional data concerning the epidemiology of the disease would
then be available.
Each case of pneumonia should be regarded as a focus for the spread
of the infection and the care of each· patient should include those ·
measures which have been found serviceable in other communicable
diseases. The patient should be isolated as far as possible and his
communication with other individuals should be reduced to a practi
cal minimum. Inasmuch as the pneumococcus finds its way to the
outside world mainly in the secretions from the buccal and respira
tory tracts, the sputum should be collected in special containers
and either burned or disinfected. All utensils, handkerchiefs, bed
clothing, etc., which are likely to become
contaminated through
'
contact with the mouth or otherwise should be sterilized before
again being put into general use.
The studies of Stillman have shown that a large percentage of
pneumonia patients contaminate the rooms which they occupy, as is
shown by the large number of instances in which strictly pathogenic
types of pneumococcus can be recovered from the dust of these
apartments. This indicates the necessity for thorough cleansing of
any room occupied by a case of pneumonia at the close of the period
of convalescence. In addition, the daily cleansing of the sick room
should be practised in such a way as to avoid dissemination of dust
narticles.
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From the studies presented above it is seen that tw(1 types
of carriers of ,pathogenic pneumococci exist: first, convalescents
from the disease, and second, healthy individuals who have not
contracted the disease themselves, but who have been in intimate
association with cases of the disease. These individuals usually carry
the pathogenic pneumococci for 3 to 4 weeks, but instances have
been observed in which the pneumococci have been harbored in
the mouth secretions for much longer periods. The control of healthy
carriers of disease-producing bacteria is one of the most difficult and
perplexing problems in the regulation of infectious diseases, and one
which has not as yet been satisfactorily solved. The ideal method
· would be to isolate and limit the contact of carriers until they
no longer harbor the organisms of disease. Such a procedure un
fortunately is not always practicable. In any case carriers of the
strictly disease-producing types of pneumococci should be instructed
to avoid promiscuous spitting, they should be told to refrain from
kissing, and they should be instructed in the proper methods of
disposing of any sputum or expectoration. Disinfecting mouth
washes have proved of some advantage in eliminating the organisms
from the nasopharyngeal secretions of meningococcus carriers, and
it is possible that a similar method may prove of service in shorten
ing the period of time in which convalescents from lobar pneumonia
or pneumococcus carriers harbor the pathogenic organisms in the
mouth. This procedure has not yet been carefully tried. In con
valescents it is not likely to prove of great value, however, because
the pneumococci are probably present in the deeper air passages not
reached by the disinfectant.
It is well known that epidemics of lobar pneumonia often arise
and attain considerable proportions in small communities in which
people live in close association with one another, such as military
barracks, labor compounds, schools, asylums, hospitals, prisons, etc.
It is under these conditions that the preventive measures described
above should prove of the greatest value. In the control of an
epidemic disease it is necessary that prophylactic measures should
-oe· instituted coincidently with the development of _the .first cases,
in order to prevent the wide dissemination of the virus and the con
sequent failure of all precautionary methods. Therefore, upon the
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outbreak of pneumonia in such communities as military barracks,
all patients should be immediately isolated, their contact with
other individuals cut off, and a search for carriers of the diseas�
producing types of pneumococcus made among their associates.
The carriers found should be isolated, or at least made as harmless.
as possible, by instituting the measures mentioned above. It is.
only in this way that the distribution of the pneumococcus <1,nd the
·resulting high prevalence of pneumonia can be prevented.
Prophylactic Vaccination.
Animal experiments have shown that it is very easy to produce
active immunity to pneumococci by the injection of small doses of
dead organisms, even in animals as susceptible as the mouse and
rabbit, and this immunity persists for a considerable time. It is.
theoretically possible, therefore, to immunize men to the fixed types.
of pneumococci by the injection of dead cultures. The advisability
of doing this in a civilian population under ordinary conditions has.
never been seriously considered. There are undoubtedly mark,edi
differences in th� susceptibility of individuals to pneumococcus in
fection, just as there are differences among individuals in susceptibility
to diphtheria. The so called Schick test has made the detection of
individuals who are immune to diphtheria possible. If a similar
method were applicable in pneumonia, so that persons either sus.--:
ceptible or immune to pneumococcus infection could be readily de
termined, the number whom it would be necessary to immunize could
be greatly reduced, and probably the immunization of the entire
population against infection, with certain types of pneumococci at
least, would be both practical and possible.
Even in the absence of methods of differentiating the susceptible
individuals from the immune, ho:wever, whenever pneumonia exists to
an extraordinary degree among certain groups of individuals, and in
the case of epidemics, the question of preventive inoculation should be
considered. The only place, to our knowledge, where this has· been
attempted on a large scale has been among the workers in the mines.
in South Africa, where the disease prevails to a most alarming de
gree an� causes the death of very large numbers of na,tive workmen ..
These efforts were made during 1911 and 1912 under the direction of
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Sir Almroth Wright (35). In spite of the many conclusions and
hypotheses presented in the elaborate report of this work, no definite
results as to the efficacy of the procedure were obtained. No
effort was made to immunize the men against the different specific
types of pneumococci; indeed no attention was paid to differences
in type, and it is therefore evident that the work could only re
sult in confusion. Later Lister (9, 10) carried on experimental
studies in the South African Institute for Medical Research, both on
.animals and man, and established certain facts which may go far in
making this method of prevention of pneumonia one of great value.
.He first determined the types of pneumococci causing the prevailing
pneumonia, and learned that, in addition to the types found in Europe
.and the UI½ted States,. at least one additional type exists, which is
-0ne of those most frequently encountered there. He then studied the
production of active immunity to these various types in animaJs,
and also investigated for the first time the best method of producing
immunity in man. He has found that it is easier to produce immunity
by intravenous than by subcutaneous injection. However, by the
injection of. sufficiently large doses of vaccine he has, been able to pro
duce immunity in man by subcutaneous injection. The tests of
immunity employed consisted in demonstrating the presence of ag
glutinins and opsonins in the blood. It may be objected that these
methods do not necessarily indicate active immunity. However, as
far as animal studies may be applicable, it has been the experience of
.all investigators that animals whose blood contains these antibodies
.are always actively immune. We therefore believe that these tests
.are perfectly justifiable and reliable in judging of the presence of
.active immunity. As we have stated elsewhere, estimations of pro
tective power probably give more accurate quantitative indications of
immunity, but in the present circumstance such great accuracy is not
jmportant. From Lister's studies he concluded that for prophylactic
purposes "three subcutaneous inoculations, at 7 days' jnterval,
.ghould be employed; each dose should consist of 6,000 million cocc;i
,of each group against which immunity is desired." He found that 8
months after the last inoculation his own serum still contained
.agglutinins and opsonins against the types of organisms injected.
Re has found that the reactions following the injection of even
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very large doses of vaccine are slight. Our experience fully bears
this out. These observations of Lister are of great · value and
importance. Our studies on the production of immunity in animals
-(R31), however, suggest strongly that more effective and rapid im
munity may be produced by the frequent injection of small amounts
of vaccine than by the infrequent injection of large amounts. Such a
method of immunization, however, involves practical considerations,
the discussion of which cannot be entered into here. The important
fact is that active immunity may be produced against the specific
types of pneumococci and that this immunity persists for a con
siderable length of time. The question of the advisability of active
immunization against pneumonia is now a very acute and important
one, since within a short time large numbers of susceptible men will
be collected together in soldiers' camps, and it is probable that, unless
preventive measures are instituted, large numbers of them will be
attacked by the. disease. Before preventive inoculation is undertaken
on a large scale, certain questions must be answered: Is it justifiable
or practicable to subject large numbers of men to the resulting
inconvenience and loss of time in the hope of protecting a number
of them from this serious disease? If this method is employed, how
may the highest grade of immunity be produced, what should be the
size of the dose, the site of injection, the frequency and nwnber of
injections, and what is the best form of antigen to be eJl?.ployed?
A number of these problems are now being studied. The results of
such a method of prophylaxis cannot, .of course, be foretold with
accuracy. We can only say that as far as experiments on animals
are of value, the employment of this method would result in great
saving of human life. A trial· of this method in army camps has
already been strongly recommended by Major Nichols (18) of the
United States Army.
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